Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
Svetlana Mojsov, … , Gordon C. Weir, Joel F. Habener
Svetlana Mojsov, … , Gordon C. Weir, Joel F. Habener
Published February 1, 1987
Citation Information: J Clin Invest. 1987;79(2):616-619. https://doi.org/10.1172/JCI112855.
View: Text | PDF
Research Article Article has an altmetric score of 52

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

  • Text
  • PDF
Abstract

Insulin secretion is controlled by a complex set of factors that include not only glucose but amino acids, catecholamines, and intestinal hormones. We report that a novel glucagon-like peptide, co-encoded with glucagon in the glucagon gene is a potent insulinotropic factor. The glucagon gene encodes a proglucagon that contains in its sequence glucagon and additional glucagon-like peptides (GLPs). These GLPs are liberated from proglucagon in both the pancreas and intestines. GLP-I exists in at least two forms: 37 amino acids GLP-I(1-37), and 31 amino acids, GLP-I(7-37). We studied the effects of synthetic GLP-Is on insulin secretion in the isolated perfused rat pancreas. In the presence of 6.6 mM glucose, GLP-I(7-37) is a potent stimulator of insulin secretion at concentrations as low as 5 X 10(-11) M (3- to 10-fold increases over basal). GLP-I(1-37) had no effect on insulin secretion even at concentrations as high as 5 X 10(-7) M. The earlier demonstration of specific liberation of GLP-I(7-37) in the intestine and pancreas, and the magnitude of the insulinotropic effect at such low concentrations, suggest that GLP-I(7-37) participates in the physiological regulation of insulin secretion. Images

Authors

Svetlana Mojsov, Gordon C. Weir, Joel F. Habener

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1985 1964 Total
Citations: 5 23 12 13 21 12 24 25 18 31 19 35 24 15 130 39 17 23 16 18 14 13 12 9 11 16 11 13 10 18 17 12 13 18 11 12 11 10 5 1 1 758
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (758)

Title and authors Publication Year
Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus
He X, Zhao W, Li P, Zhang Y, Li G, Su H, Lu B, Pang Z
Frontiers in Pharmacology 2025
Glucose-dependent insulinotropic polypeptide (GIP)
Müller TD, Adriaenssens A, Ahrén B, Blüher M, Birkenfeld AL, Campbell JE, Coghlan MP, D'Alessio D, Deacon CF, DelPrato S, Douros JD, Drucker DJ, Figueredo Burgos NS, Flatt PR, Finan B, Gimeno RE, Gribble FM, Hayes MR, Hölscher C, Holst JJ, Knerr PJ, Knop FK, Kusminski CM, Liskiewicz A, Mabilleau G, Mowery SA, Nauck MA, Novikoff A, Reimann F, Roberts AG, Rosenkilde MM, Samms RJ, Scherer PE, Seeley RJ, Sloop KW, Wolfrum C, Wootten D, DiMarchi RD, Tschöp MH
Molecular Metabolism 2025
Oppositely biased glucagon‐like peptide‐1 receptor agonism does not differentially affect lipid metabolism in APOE*3‐Leiden CETP mice
Modder M, Tomas A, Afkir S, Pronk AC, Streefland TC, Lalai RA, van Eenige R, Rensen PC, Jones B, Kooijman S
Diabetes, Obesity & Metabolism 2025
GLP-1-based therapies for diabetes, obesity and beyond.
Drucker DJ
Nature reviews. Drug discovery 2025
Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies
Park JS, Kim KS, Choi HJ
Diabetes & Metabolism Journal 2025
Targeting the incretin system in obesity and type 2 diabetes mellitus.
Ansari S, Khoo B, Tan T
Nature reviews. Endocrinology 2024
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets
Reed J, Bain SC, Kanamarlapudi V
2024
A comprehensive in-vitro/in-vivo screening toolbox for the elucidation of glucose homeostasis modulating properties of plant extracts (from roots) and its bioactives
Bauer I, Rimbach G, Cordeiro S, Bosy-Westphal A, Weghuber J, Ipharraguerre IR, Lüersen K
Frontiers in pharmacology 2024
Impacts of different pancreatic resection ranges on endocrine function in Suncus murinus
Li RJ, Yang T, Zeng YH, Natsuyama Y, Ren K, Li J, Nagakawa Y, Yi SQ
World journal of gastrointestinal surgery 2024
Transforming Obesity: The Advancement of Multi-Receptor Drugs
Kusminski CM, Perez-Tilve D, Müller TD, DiMarchi RD, Tschöp MH, Scherer PE
Cell 2024
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu QK
Frontiers in Endocrinology 2024
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng JN, Jin T
2024
Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Hoffman S, Adeli K
2024
A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion
Montaner M, Denom J, Simon V, Jiang W, Holt MK, Brierley DI, Rouch C, Foppen E, Kassis N, Jarriault D, Khan D, Eygret L, Mifsud F, Hodson DJ, Broichhagen J, Van Oudenhove L, Fioramonti X, Gault V, Cota D, Reimann F, Gribble FM, Migrenne-Li S, Trapp S, Gurden H, Magnan C
Nature Communications 2024
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management.
Holst JJ
Nature metabolism 2024
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff A, Müller TD
Physiology 2024
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J
Signal Transduction and Targeted Therapy 2024
Obesity-drug pioneers win prestigious Lasker Award for medical science.
Lenharo M
Nature 2024
The discovery and development of GLP-1 based drugs that have revolutionized the treatment of obesity
Friedman JM
Proceedings of the National Academy of Sciences of the United States of America 2024
QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award
Nair P
Proceedings of the National Academy of Sciences of the United States of America 2024
Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of Obesity.
Parums DV
Medical science monitor : international medical journal of experimental and clinical research 2024
Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1.
Ardehali H
The Journal of clinical investigation 2024
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
Jin T, Chen YE
Cardiovascular drugs and therapy 2024
Incretin and glucagon receptor polypharmacology in chronic kidney disease
McFarlin BE, Duffin KL, Konkar A
American Journal of Physiology - Endocrinology and Metabolism 2024
Annual Prize Lecture 2024: Endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes
Holst JJ
The Journal of Physiology 2024
Design, Structure–Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor Agonists
Sawyer JR, Audie JA, Swanson J, Diller D, Santiago S, Gribkoff VK, Ackerman A, Hruby VJ, Gobbo G, Bellucci MA, Glauser WA, Pentelute BL, Sawyer TK
Molecules 2024
The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties
Lu C, Xu C, Yang J
Medicina 2024
A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure
Gul U, Aung T, Martin M, Farrukh DN, Shah PC, Lovely ZS, Marroquín León E, Alansaari M, Maini S, Fariduddin MM, Ullah A, Nazir Z
Cureus 2024
Therapeutics in Metabolic Diseases.
Natesan V
Advances in experimental medicine and biology 2023
GLP-1R Signaling and Functional Molecules in Incretin Therapy
Wan W, Qin Q, Xie L, Zhang H, Wu F, Stevens RC, Liu Y
Molecules (Basel, Switzerland) 2023
Dual gut hormone receptor agonists for diabetes and obesity.
Bass J, Tschöp MH, Beutler LR
Journal of Clinical Investigation 2023
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond.
Viljoen A, Bain SC
2023
The expanding incretin universe: from basic biology to clinical translation.
Drucker DJ, Holst JJ
Diabetologia 2023
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney AC, Das S, Kumar D, McKinney MP, Cai B, Yurdagul A Jr, Rom O
Frontiers in Cardiovascular Medicine 2023
Incretin hormones and type 2 diabetes.
Nauck MA, Müller TD
Diabetologia 2023
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application
Campbell JE, Müller TD, Finan B, DiMarchi RD, Tschöp MH, D\u2019Alessio DA
Cell Metabolism 2023
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist.
Cho YK, La Lee Y, Jung CH
Journal of Lipid and Atherosclerosis 2023
The Role of Genistein in Mammalian Reproduction.
Guelfi G, Pasquariello R, Anipchenko P, Capaccia C, Pennarossa G, Brevini TAL, Gandolfi F, Zerani M, Maranesi M
Molecules (Basel, Switzerland) 2023
Comparison of SGLT1, SGLT2, and Dual Inhibitor biological activity in treating Type 2 Diabetes Mellitus
Azizogli AR, Vitti MR, Mishra R, Osorno L, Heffernan C, Kumar VA
2023
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
Folli F, Finzi G, Manfrini R, Galli A, Casiraghi F, Centofanti L, Berra C, Fiorina P, Davalli A, La Rosa S, Perego C, Higgins PB
American journal of physiology. Endocrinology and metabolism 2023
Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β -cell dysfunction
N Esser, S Mongovin, J Parilla, B Barrow, T Mundinger, B Fountaine, M Larmore, J Castillo, R Akter, R Hull, S Zraika
American journal of physiology. Endocrinology and metabolism 2022
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
Sharma A, Virmani T, Sharma A, Chhabra V, Kumar G, Pathak K, Alhalmi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022
State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions
Lavin KM, Coen PM, Baptista LC, Bell MB, Drummer D, Harper SA, Lixandrão ME, McAdam JS, O\u2019Bryan SM, Ramos S, Roberts LM, Vega RB, Goodpaster BH, Bamman MM, Buford TW
Comprehensive Physiology 2022
14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing
Holter MM, Phuong DJ, Lee I, Saikia M, Weikert L, Fountain S, Anderson ET, Fu Q, Zhang S, Sloop KW, Cummings BP
Science Advances 2022
Physiological Systems in Promoting Frailty
Perazza LR, Brown-Borg HM, Thompson LV
Comprehensive Physiology 2022
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology.
Sebastián-Martín A, Sánchez BG, Mora-Rodríguez JM, Bort A, Díaz-Laviada I
Biomedicines 2022
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion.
Hjørne AP, Modvig IM, Holst JJ
Metabolites 2022
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
Pang J, Feng JN, Ling W, Jin T
Acta pharmaceutica Sinica. B 2022
Safety and effectiveness of newer antidiabetic medications during Ramadan fasting and safety of Ramadan fasting after bariatric surgery.
Ahmed M, Badi S, Elidrisi A, Husain NE, Zainudin SB, Mahmood A, Abubaker NE, Alghamdi AS, Ahmed MH
2022
The Anti-Inflammatory Effect of Novel Antidiabetic Agents.
Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis K, Tousoulis D
2022
The importance of estradiol for body weight regulation in women.
Vigil P, Meléndez J, Petkovic G, Del Río JP
Frontiers in Endocrinology 2022
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease.
Du H, Meng X, Yao Y, Xu J
Frontiers in Endocrinology 2022
Development of sandwich ELISAs for detecting glucagon-like peptide-1 secretion from intestinal L-cells and their application in STC-1 cells and mice.
Odongo K, Hironao KY, Yamashita Y, Ashida H
Journal of Clinical Biochemistry and Nutrition 2022
The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
MA Nauck, DR Quast, J Wefers, AF Pfeiffer
Diabetes, obesity & metabolism 2021
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
L D'Marco, V Morillo, JL Gorriz, MK Suarez, M Nava, Á Ortega, H Parra, N Villasmil, J Rojas-Quintero, V Bermúdez, M Wallner
Journal of Diabetes Research 2021
AMPK in the brain: its roles in glucose and neural metabolism
R Muraleedharan, B Dasgupta
The FEBS journal 2021
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
J Rosenberg, J Jacob, P Desai, J Park, L Donovan, JY Kim
Journal of Obesity & Metabolic Syndrome 2021
Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo
Y Dong, J Carty, N Goldstein, Z He, E Hwang, D Chau, B Wallace, A Kabahizi, L Lieu, Y Peng, Y Gao, L Hu, JN Betley, KW Williams
Molecular Metabolism 2021
The specification and function of enteroendocrine cells in Drosophila and mammals: a comparative review
X Guo, J Lv,
The FEBS journal 2021
GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
QX Li, H Gao, YX Guo, BY Wang, R Hua, L Gao, HW Shang, X Lu, JD Xu
Frontiers in Endocrinology 2021
Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
N Tanday, PR Flatt, N Irwin
British Journal of Pharmacology 2021
Editorial: Proglucagon-Derived Peptides
PR Flatt, FK Knop, AI Tarasov
Frontiers in Endocrinology 2021
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
J Helmstädter, K Keppeler, L Küster, T Münzel, A Daiber, S Steven
British Journal of Pharmacology 2021
The incretin/glucagon system as a target for pharmacotherapy of obesity.
Del Prato S, Gallwitz B, Holst JJ, Meier JJ
Obesity reviews : an official journal of the International Association for the Study of Obesity 2021
Multi-omic Approaches to Identify Genetic Factors in Metabolic Syndrome
Clark KC, Kwitek AE
Comprehensive Physiology 2021
On premises and principles for measurement of gastrointestinal peptide hormones
NJ Albrechtsen, JF Rehfeld
Peptides 2021
Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior
S Jones, S Luo, HM Dorton, AG Yunker, B Angelo, A Defendis, JR Monterosso, KA Page
Frontiers in Endocrinology 2021
Effective and safe delivery of GLP-1AR and FGF-21 plasmids using amino-functionalized dual-mesoporous silica nanoparticles in vitro and in vivo
S Geng, L Qin, Y He, X Li, M Yang, L Li, D Liu, Y Li, D Niu, G Yang
Biomaterials 2021
The islet’s bridesmaid becomes the bride: Proglucagon-derived peptides deliver transformative therapies
S ORahilly
Cell 2021
Is there a role for glucagon‐like peptide‐1 receptor agonists in the treatment of male infertility?
R Cannarella, AE Calogero, RA Condorelli, EA Greco, A Aversa, SL Vignera
Andrologia 2021
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
QG Karwi, KL Ho, S Pherwani, EB Ketema, QY Sun, GD Lopaschuk
Cardiovascular Research 2021
Прямое действие синтетического аналога глюкагон-подобного пептида 1-го типа, лираглутида, на зрелые адипоциты реализуется через аденилатциклаза-зависимое усиление инсулиновой чувствительности
ЕД Мамонтова, СС Мичурина, ЮС Стафеев, ЕЛ Соркина, ИА Скляник, ЕО Кокшарова, МЮ Меньшиков, МВ Шестакова, ЕВ Парфёнова
2021
Sodium Glucose Transporter, Type 2 (SGLT2) Inhibitors (SGLT2i) and Glucagon-Like Peptide 1-Receptor Agonists: Newer Therapies in Whole-Body Glucose Stabilization
BD Shepard, CM Ecelbarger
Seminars in Nephrology 2021
The incretin/glucagon system as a target for pharmacotherapy of obesity
SD Prato, B Gallwitz, JJ Holst, JJ Meier
Obesity reviews : an official journal of the International Association for the Study of Obesity 2021
Development of innovative tools for investigation of nutrient-gut interaction
WK Huang, C Xie, RL Young, JB Zhao, H Ebendorff-Heidepriem, KL Jones, CK Rayner, TZ Wu
World journal of gastroenterology : WJG 2020
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
K Stemmer, B Finan, RD DiMarchi, MH Tschöp, TD Müller
Advanced Drug Delivery Reviews 2020
The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
MA Nauck
Metabolism 2020
AMPK in the Ventromedial Nucleus of the Hypothalamus: A Key Regulator for Thermogenesis
H Liu, Y Xu, F Hu
Frontiers in Endocrinology 2020
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
MA Nauck, DR Quast, J Wefers, JJ Meier
Molecular Metabolism 2020
Reframing appetitive reinforcement learning and reward valuation as effects mediated by hippocampal-dependent behavioral inhibition
S Jones, A Hyde, TL Davidson
Nutrition research (New York, N.Y.) 2020
Glucagon-like Peptide-1: Actions and Influence on Pancreatic Hormone Function
Davis EM, Sandoval DA
Comprehensive Physiology 2020
GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists
JJ Holst, MM Rosenkilde
The Journal of clinical endocrinology and metabolism 2020
Engineering Xaa-Pro dipeptidyl aminopeptidase for specific cleavage of glucagon and glucagon-like peptide 1 from fusion proteins
E Vernet, MØ Pedersen, H Thøgersen, AC Shaw
Protein Expression and Purification 2020
The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone
V Marks
Peptides 2020
Obesity and Diabetes: Scientific Advances and Best Practice
J Faintuch, S Faintuch
2020
Aging-related modifications to G protein-coupled receptor signaling diversity
J van Gastel, H Leysen, J Boddaert, L van Genechten, LM Luttrell, B Martin, S Maudsley
Pharmacology & Therapeutics 2020
CNS-targeting pharmacological interventions for the metabolic syndrome
Kerstin Stemmer, Timo D. Müller, Richard DiMarchi, Paul T. Pfluger, Matthias H. Tschoep
Journal of Clinical Investigation 2019
Incretins in obesity and diabetes
CW Chia, JM Egan
Annals of the New York Academy of Sciences 2019
The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism
Y Yu, F Raka, K Adeli
Journal of Clinical Medicine 2019
Intestinal Fructose and Glucose Metabolism in Health and Disease
B Merino, CM Fernández-Díaz, I Cózar-Castellano, G Perdomo
Nutrients 2019
The Discovery and Development of Liraglutide and Semaglutide
LB Knudsen, J Lau
Frontiers in Endocrinology 2019
Glucagon-like peptide 1 (GLP-1)
TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, A Fritsche, F Gribble, HJ Grill, JF Habener, JJ Holst, W Langhans, JJ Meier, MA Nauck, D Perez-Tilve, A Pocai, F Reimann, DA Sandoval, TW Schwartz, RJ Seeley, K Stemmer, M Tang-Christensen, SC Woods, RD DiMarchi, MH Tschöp
Molecular Metabolism 2019
Intestinal electrical stimulation attenuates hyperglycemia and prevents loss of pancreatic β cells in type 2 diabetic Goto–Kakizaki rats
X Ouyang, S Li, Y Tan, L Lin, J Yin, JD Chen
Nutrition and Diabetes 2019
Regulation of Memory Function by Feeding-Relevant Biological Systems: Following the Breadcrumbs to the Hippocampus
AN Suarez, EE Noble, SE Kanoski
Frontiers in molecular neuroscience 2019
Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment
MM Chen, JJ Cai, Y Yu, ZG She, H Li
Gene expression 2019
Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity
LB Knudsen
2019
Glucagon, GLP-1 and Thermogenesis
I González-García, E Milbank, C Diéguez, M López, C Contreras
International journal of molecular sciences 2019
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
JJ Holst
Frontiers in Endocrinology 2019
Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen
L Zhu, J Zhou, Y Pan, J Lv, Y Liu, S Yu, Y Zhang
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2019
Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date.
Pearson S, Kietsiriroje N, Ajjan RA
Diabetes, metabolic syndrome and obesity : targets and therapy 2019
Curcuma supplementation in high-fat-fed C57BL/6 mice: no beneficial effect on lipid and glucose profile or prevention of weight gain
CB Silva, PG Fassini, LN Ramalho, EC da Conceição, AJ Zordan, D Carlos, VM Suen
European Journal of Nutrition 2019
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
C F.
Frontiers in Endocrinology 2019
Improving Effects of Peptides on Brain Malfunction and Intranasal Delivery of Those Derivatives to the Brain
JI Oka
YAKUGAKU ZASSHI 2019
Dietary Flavonoids for Immunoregulation and Cancer: Food Design for Targeting Disease
J Ahn-Jarvis, A Parihar, A Doseff
Antioxidants 2019
Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency
SE Alavi, PJ Cabot, PM Moyle
Molecular Pharmaceutics 2019
Enteroendocrine Connections in Congenital Isolated GH Deficiency Due to a GHRH Receptor Gene Mutation
AA Oliveira-Santos, R Salvatori, MC Nogueira, AC Bueno, CS Barros-Oliveira, ÂC Leal, CG Marinho, NP Damascena, DA Oliveira, MA Melo, CR Oliveira, FO da Costa, JS dos Santos, PF Santos, VC Campos, EG Santos, EV Melo, ML Barbosa, IE Rocha, M de Castro, MH Aguiar-Oliveira
The Journal of clinical endocrinology and metabolism 2019
Molecular evolution of GIP and Exendin and their receptors
DM Irwin
Peptides 2019
The early history of GIP 1969–2000: From enterogastrone to major metabolic hormone
V Marks
Peptides 2019
The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective
PB Jeppesen
Digestive Diseases and Sciences 2019
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome
DJ Drucker
2019
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
C Clemmensen, B Finan, T Müller, R DiMarchi, M Tschöp, S Hofmann
Nature Reviews Endocrinology 2018
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
TD Müller, C Clemmensen, B Finan, RD DiMarchi, MH Tschöp, B Holst
Pharmacological reviews 2018
Liraglutide Enhances the Activity of the ACE-2/Ang(1–7)/Mas Receptor Pathway in Lungs of Male Pups from Food-Restricted Mothers and Prevents the Reduction of SP-A
J Fandiño, AA Vaz, L Toba, M Romaní-Pérez, L González-Matías, F Mallo, Y Diz-Chaves
International Journal of Endocrinology 2018
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
ME Capozzi, RD DiMarchi, MH Tschöp, B Finan, JE Campbell
Endocrine reviews 2018
GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice
P Kumari, M Nakata, BY Zhang, Z Otgon-Uul, T Yada
Biochemical and Biophysical Research Communications 2018
Hypoglycemic Effects of Intestinal Electrical Stimulation by Enhancing Nutrient-Stimulated Secretion of GLP-1 in Rats
F Ye, Y Liu, S Li, JD Chen
Obesity Surgery 2018
Incretin hormones: Their role in health and disease
MA Nauck, JJ Meier
Diabetes, obesity & metabolism 2018
Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease
HY Cai, JT Yang, ZJ Wang, J Zhang, W Yang, MN Wu, JS Qi
Biochemical and Biophysical Research Communications 2018
The Origin and Understanding of the Incretin Concept
JF Rehfeld
Frontiers in Endocrinology 2018
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
C F.
Peptides 2018
Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control
LL Lehrskov, MP Lyngbaek, L Soederlund, GE Legaard, JA Ehses, SE Heywood, NJ Albrechtsen, JJ Holst, K Karstoft, BK Pedersen, H Ellingsgaard
Cell Metabolism 2018
Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure
T Kimura, A Obata, M Shimoda, H Hirukawa, Y Kanda-Kimura, Y Nogami, K Kohara, S Nakanishi, T Mune, K Kaku, H Kaneto
Diabetes & Metabolism 2018
A surface plasmon resonance assay for characterisation and epitope mapping of anti-GLP-1 antibodies
L Thomsen, L Gurevich
Journal of molecular recognition : JMR 2018
T1R2 receptor-mediated glucose sensing in the upper intestine potentiates glucose absorption through activation of local regulatory pathways
K Smith, E Karimian-Azari, TE LaMoia, T Hussain, V Vargova, K Karolyi, PP Veldhuis, JP Arnoletti, SG de la Fuente, RE Pratley, TF Osborne, GA Kyriazis
Molecular Metabolism 2018
Exenatide preserves trabecular bone microarchitecture in experimental ovariectomized rat model
E Eminov, I Hortu, L Akman, O Erbas, A Yavasoglu, T Cirpan
Archives of Gynecology and Obstetrics 2018
Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice
R Hytting-Andreasen, E Balk-Møller, B Hartmann, J Pedersen, JA Windeløv, JJ Holst, H Kissow, GD Pasquale
PloS one 2018
Diversification of the functions of proglucagon and glucagon receptor genes in fish
DM Irwin, S Mojsov
General and Comparative Endocrinology 2018
A molecular docking study of Rhizoma Atractylodis and Rhizoma Atractylodis Macrocephalae herbal pair with respect to type 2 diabetes mellitus
C Chen, S Zhou, Q Meng
Journal of Traditional Chinese Medical Sciences 2018
Pyrrole: An insight into recent pharmacological advances with structure activity relationship
S Ahmad, O Alam, MJ Naim, M Shaquiquzzaman, MM Alam, M Iqbal
European Journal of Medicinal Chemistry 2018
Blackcurrant Extract Ameliorates Hyperglycemia in Type 2 Diabetic Mice in Association with Increased Basal Secretion of Glucagon-Like Peptide-1 and Activation of AMP-Activated Protein Kinase
Y IIZUKA, A OZEKI, T TANI, T TSUDA
Journal of Nutritional Science and Vitaminology 2018
Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists
GV Graham, JM Conlon, YH Abdel-Wahab, PR Flatt
Molecular and Cellular Endocrinology 2018
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
F Bifari, R Manfrini, MD Cas, C Berra, M Siano, M Zuin, R Paroni, F Folli
Pharmacological research : the official journal of the Italian Pharmacological Society 2018
Peptide-based multi-agonists: a new paradigm in metabolic pharmacology
SJ Brandt, TD Müller, RD DiMarchi, MH Tschöp, K Stemmer
Journal of Internal Medicine 2018
Relationship between glucagon like peptide-1 and non-alcoholic fatty liver disease in diabetic and non-diabetic patients
N Sheriba, M Samy, C Adel, S Anas
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
C Clemmensen, B Finan, TD Müller, RD DiMarchi, MH Tschöp, SM Hofmann
Nature Reviews Endocrinology 2018
Discovery, characterization and clinical development of the glucagon-like peptides
Daniel Drucker, Joel F. Habener, Jens J. Holst
Journal of Clinical Investigation 2017
A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion
M Shigeto, CY Cha, P Rorsman, K Kaku
Journal of Molecular Medicine 2017
The dynamic plasticity of insulin production in β-cells
BB Boland, CJ Rhodes, JS Grimsby
Molecular Metabolism 2017
The Role of the Autonomic Nervous System in the Pathophysiology of Obesity
D Guarino, M Nannipieri, G Iervasi, S Taddei, RM Bruno
Frontiers in physiology 2017
Dietary polyunsaturated fatty acids and their metabolites: Implications for diabetes pathophysiology, prevention, and treatment
JC Neuman, RJ Fenske, ME Kimple
Nutrition and Healthy Aging 2017
The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms
C Zhao, J Liang, Y Yang, M Yu, X Qu
Frontiers in Endocrinology 2017
Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors
Y Zhang, M Wu, W Htun, EW Dong, F Mauvais-Jarvis, VA Fonseca, H Wu
Scientific Reports 2017
Venom peptides as pharmacological tools and therapeutics for diabetes
SD Robinson, H Safavi-Hemami
Neuropharmacology 2017
Obesity and Brain Function
L Letra, R Seiça
Obesity and Brain Function 2017
Delphinidin 3-rutinoside-rich blackcurrant extract ameliorates glucose tolerance by increasing the release of glucagon-like peptide-1 secretion
T Tani, S Nishikawa, M Kato, T Tsuda
Food Science & Nutrition 2017
Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice
PK Huang, SX Lin, MJ Tsai, M Leong, SR Lin, R Kankala, CH Lee, CF Weng
Nanomaterials 2017
Dietary Fiber in Health and Disease
ML Dreher
Dietary Fiber in Health and Disease 2017
The New Biology and Pharmacology of Glucagon
TD Müller, B Finan, C Clemmensen, RD DiMarchi, MH Tschöp
Physiological reviews 2017
TEMPORARY REMOVAL: Rebirth of the Incretin Concept: Its conception and early development
V Marks
Peptides 2017
Suppression of circadian secretion of glucagon-like peptide-1 by the saturated fatty acid, palmitate
A Martchenko, RH Oh, SE Wheeler, P Gurges, JA Chalmers, PL Brubaker
Acta physiologica (Oxford, England) 2017
Low-molecular fraction of wheat protein hydrolysate stimulates glucagon-like peptide-1 secretion in an enteroendocrine L cell line and improves glucose tolerance in rats
M Kato, T Nakanishi, T Tani, T Tsuda
Nutrition research (New York, N.Y.) 2017
Evolution of the glucagon-like system across fish
JC Cardoso, RC Félix, C Costa, PF Palma, AV Canário, DM Power
General and Comparative Endocrinology 2017
GIP („Glucose-Dependent Insulinotropic Polypeptide“) und GLP-1 („Glucagon-Like Petide-1“): Rolle in der Stoffwechselregulation und bei Diabetesmanifestation
D Quast, MA Nauck
Der Diabetologe 2017
Advances in Beta Cell Replacement and Regeneration Strategies for Treating Diabetes
Jacqueline Benthuysen, Andrea Carrano, Maike Sander
Journal of Clinical Investigation 2016
The incretin hormone GLP-1 and mechanisms underlying its secretion: Hormone GLP-1 and its secretion
L Tian, T Jin
Journal of Diabetes 2016
GLP-1 analogue recovers impaired insulin secretion from human islets treated with palmitate via down-regulation of SOCS2
AI Chowdhury, P Bergsten
Molecular and Cellular Endocrinology 2016
Human G protein-coupled receptor studies in Saccharomyces cerevisiae
R Liu, W Wong, AP IJzerman
Biochemical Pharmacology 2016
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
C Graaf, D Donnelly, D Wootten, J Lau, PM Sexton, LJ Miller, JM Ahn, J Liao, MM Fletcher, D Yang, AJ Brown, C Zhou, J Deng, MW Wang
Pharmacological reviews 2016
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology
A Tramutola, A Arena, C Cini, DA Butterfield, E Barone
Expert Review of Neurotherapeutics 2016
A dual-monoclonal, sandwich immunoassay specific for glucagon like peptide-19–36/7 (GLP-19–36/7)
RI Osborne, W Ming, JS Troutt, RW Siegel, RJ Konrad
Clinical Biochemistry 2016
Inter-organ communication and regulation of beta cell function
MA Hussain, E Akalestou, W Song
Diabetologia 2016
The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets
M Ahn, SM Yoder, Z Wang, E Oh, L Ramalingam, R Tunduguru, DC Thurmond
Diabetologia 2016
GLP-1 mimetic drugs and the risk of exocrine pancreatic disease: Cell and animal studies
JA Williams
Pancreatology 2016
Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation
E Fernández-Millán, MA Martín, L Goya, E Lizárraga-Mollinedo, F Escrivá, S Ramos, C Álvarez
Free radical biology & medicine 2016
Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamus
LB Knudsen, A Secher, J Hecksher-Sørensen, C Pyke
Journal of Diabetes Investigation 2016
Circadian Transcription from Beta Cell Function to Diabetes Pathophysiology.
Perelis M, Ramsey KM, Marcheva B, Bass J
Journal of Biological Rhythms 2016
Glucagon-like peptide-1 inhibits vascular smooth muscle cell dedifferentiation through mitochondrial dynamics regulation
G Torres, PE Morales, M García-Miguel, I Norambuena-Soto, B Cartes-Saavedra, G Vidal-Peña, D Moncada-Ruff, F Sanhueza-Olivares, AS Martín, M Chiong
Biochemical Pharmacology 2016
Handbook of Lipids in Human Function
GD Pimentel, C Contreras, M López
Handbook of Lipids in Human Function 2016
Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections
RA Pederson, CH McIntosh
Journal of Diabetes Investigation 2016
Intra-islet glucagon-like peptide 1
GE Fava, EW Dong, H Wu
Journal of Diabetes and its Complications 2016
Drug development from the bench to the pharmacy: with special reference to dipeptidyl peptidase - 4 inhibitor development
RD Carr
Diabetic Medicine 2016
Type II PKAs are anchored to mature insulin secretory granules in INS-1 β-cells and required for cAMP-dependent potentiation of exocytosis
S Villalpando, C Cazevieille, A Fernandez, NJ Lamb, EH Hani
Biochimie 2016
A new GLP-1 analogue with prolonged glucose-lowering activity in vivo via backbone-based modification at the N-terminus
X Bai, Y Niu, J Zhu, AQ Yang, YF Wu, XS Ye
Bioorganic & Medicinal Chemistry 2016
The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
F Andreozzi, GA Raciti, C Nigro, GC Mannino, T Procopio, AM Davalli, F Beguinot, G Sesti, C Miele, F Folli
Journal of Translational Medicine 2016
Histoire des incrétines : Du chien brun au monstre de Gila
JL Schlienger
Médecine des Maladies Métaboliques 2016
Principles of Diabetes Mellitus
A Ohri, S Vergano, R Bhambri, SH Schneider
Principles of Diabetes Mellitus 2016
Stereoselective Synthesis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, ( R )-Sitagliptin
R Anjibabu, JM Boggu, P Shekhar, BV Reddy
ChemistrySelect 2016
Small intestine morphology and recovery after drug-induced colitis in proglucagon-derived peptides knockout mice
M Matsushita, O Watanabe, T Ando, O Maeda, R Miyahara, M Nakamura, T Yamamura, H Goto, Y Hirooka, U Schumacher
Cogent Medicine 2016
Principles of Endocrinology and Hormone Action
A Belfiore, D LeRoith
Principles of Endocrinology and Hormone Action 2016
Circadian Transcription from Beta Cell Function to Diabetes Pathophysiology
M Perelis, KM Ramsey, B Marcheva, J Bass
Journal of Biological Rhythms 2016
Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon
DA Oren, Y Wei, L Skrabanek, BK Chow, T Mommsen, S Mojsov, JL Soengas
PloS one 2016
Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives
T Jin, J Weng
American journal of physiology. Endocrinology and metabolism 2016
GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries
C Egholm, MM Khammy, T Dalsgaard, A Mazur, K Tritsaris, AJ Hansen, C Aalkjaer, S Dissing
American journal of physiology. Heart and circulatory physiology 2016
Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion
M Kato, S Nishikawa, A Ikehata, K Dochi, T Tani, T Takahashi, A Imaizumi, T Tsuda
Molecular Nutrition & Food Research 2016
cAMP-independent effects of GLP-1 on β cells
Jelena Kolic, Patrick MacDonald
Journal of Clinical Investigation 2015
Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate ( Macaca mulatta ) Brain
KM Heppner, M Kirigiti, A Secher, SJ Paulsen, R Buckingham, C Pyke, LB Knudsen, N Vrang, KL Grove
Endocrinology 2015
Deciphering Metabolic Messages From the Gut Drives Therapeutic Innovation: The 2014 Banting Lecture
DJ Drucker
Diabetes 2015
GLP-1 based therapeutics: simultaneously combating T2DM and obesity
KM Heppner, D Perez-Tilve
Frontiers in neuroscience 2015
Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice: brain GLP-1 signaling and insulin secretion
E Tudurí, D Beiroa, B Porteiro, M López, C Diéguez, R Nogueiras
Diabetes Obesity and Metabolism 2015
Epigenetic regulation of the intestinal epithelium
EN Elliott, KH Kaestner
Cellular and Molecular Life Sciences 2015
Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent Neuron Signaling
CC Ronveaux, D Tome, HE Raybould
The Journal of nutrition 2015
Vagal mediation of GLP-1's effects on food intake and glycemia
JP Krieger, W Langhans, SJ Lee
Physiology & Behavior 2015
The Glucagon-Like Peptide-1 Receptor is Present in Pancreatic Acinar Cells and Regulates Amylase Secretion through cyclic AMP
Y Hou, SA Ernst, K Heidenreich, JA Williams
AJP Gastrointestinal and Liver Physiology 2015
Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells
T Sato, H Hayashi, M Hiratsuka, N Hirasawa
Molecular and Cellular Endocrinology 2015
Aqueous Fraction of Beta vulgaris Ameliorates Hyperglycemia in Diabetic Mice due to Enhanced Glucose Stimulated Insulin Secretion, Mediated by Acetylcholine and GLP-1, and Elevated Glucose Uptake via Increased Membrane Bound GLUT4 Transporters
AU Kabir, MB Samad, A Ahmed, MR Jahan, F Akhter, J Tasnim, SM Hasan, SS Sayfe, JM Hannan, C Miele
PloS one 2015
Gastrointestinal hormone research – with a Scandinavian annotation
JF Rehfeld
Scandinavian Journal of Gastroenterology 2015
Postnatal weight gain induced by overfeeding pups and maternal high-fat diet during the lactation period modulates glucose metabolism and the production of pancreatic and gastrointestinal peptides
Q Du, H Hosoda, T Umekawa, T Kinouchi, N Ito, M Miyazato, K Kangawa, T Ikeda
Peptides 2015
The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+/Calmodulin-Dependent Kinase II Pathway
M Kato, T Tani, N Terahara, T Tsuda, T Jin
PloS one 2015
Glucose-dependent insulinotropic polypeptide directly induces glucose transport in rat skeletal muscle
LA Snook, EM Nelson, DJ Dyck, DC Wright, GP Holloway
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2015
Ghrelin regulates GLP-1 production through mTOR signaling in L cells
G Xu, X Hong, H Tang, S Jiang, F Liu, Z Shen, Z Li, W Zhang
Molecular and Cellular Endocrinology 2015
Clinical use of GLP-1 agonists and DPP4 inhibitors
BE Tuch
Pancreatology 2015
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
DA Sandoval, DA D'Alessio
Physiological reviews 2015
Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
M Romaní-Pérez, V Outeiriño-Iglesias, CM Moya, P Santisteban, LC González-Matías, E Vigo, F Mallo
Endocrinology 2015
Gluco-incretins regulate Beta-cell glucose competence by epigenetic silencing of fxyd3 expression
D Vallois, G Niederhäuser, M Ibberson, V Nagaray, L Marselli, P Marchetti, JY Chatton, B Thorens
PloS one 2014
GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
D Beiroa, M Imbernon, R Gallego, A Senra, D Herranz, F Villarroya, M Serrano, J Ferno, J Salvador, J Escalada, C Dieguez, M Lopez, G Fruhbeck, R Nogueiras
Diabetes 2014
Molecular dynamic simulations reveal the mechanism of binding between xanthine inhibitors and DPP-4
Y Gu, W Wang, X Zhu, K Dong
Journal of Molecular Modeling 2014
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation: Molecular physiology of GLP-1R
K Pabreja, MA Mohd, C Koole, D Wootten, SG Furness
British Journal of Pharmacology 2014
Cardiovascular and hemodynamic effects of glucagon-like peptide-1
AG Goodwill, KJ Mather, AM Conteh, DJ Sassoon, JN Noblet, JD Tune
Reviews in Endocrine and Metabolic Disorders 2014
Regulation of glucose homeostasis by GLP-1
P Nadkarni, OG Chepurny, GG Holz
Progress in molecular biology and translational science 2014
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease 2014
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease 2014
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease 2014
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease 2014
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease 2014
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease
M Lyte, JF Cryan
Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease 2014
Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat
M López, C Diéguez, R Nogueiras
Adipocyte 2014
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women
SK Hegazy
Journal of Bone and Mineral Metabolism 2014
Evaluation of Intragastric Vs Intraperitoneal Glucose Tolerance Tests in the Evaluation of Insulin Resistance in a Rodent Model of Burn Injury and Glucagon-Like Polypeptide-1 Treatment:
S Watada, YM Yu, AJ Fischman, T Kurihara, C Shen, RG Tompkins, S Fagan
Journal of Burn Care & Research 2014
Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats
K Tanaka, Y Masaki, M Tanaka, M Miyazaki, M Enjoji, M Nakamuta, M Kato, M Nomura, T Inoguchi, K Kotoh, R Takayanagi
World journal of gastroenterology : WJG 2014
Polyphenols in Human Health and Disease
BK Tan, KW Ong
Polyphenols in Human Health and Disease 2014
Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report
FK Knop, A Lund, S Madsbad, JJ Holst, T Krarup, T Vilsbøll
BMC Research Notes 2014
Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells
ZQ Zhu, D Wang, D Xiang, YX Yuan, Y Wang
Metabolism 2014
Effects of sitagliptin on plasma incretin concentrations after glucose administration through an esophagostomy tube or feeding in healthy cats
N Nishii, S Takashima, A Iguchi, Y Murahata, A Matsuu, Y Hikasa, H Kitagawa
Domestic Animal Endocrinology 2014
GLP-1-related proteins attenuate the effects of mitochondrial membrane damage in pancreatic β cells
M Ogata, N Iwasaki, R Ide, M Takizawa, Y Uchigata
Biochemical and Biophysical Research Communications 2014
Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
X Ji, M Su, J Wang, G Deng, S Deng, Z Li, C Tang, J Li, J Li, L Zhao, H Jiang, H Liu
European Journal of Medicinal Chemistry 2014
Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents: GLP-1 Prevents Inflammation-Induced Dysfunction
T Iwai, T Sawabe, K Tanimitsu, M Suzuki, S Sasaki-Hamada, JI Oka
Journal of Neuroscience Research 2014
Should we still be concerned about the potential side effects of glucagon-like peptide-1 receptor agonists on thyroid C cells?
Y Cao, XM Liu
Endocrine 2014
GLP-1: The Oracle for Gastric Bypass?
G Fruhbeck, R Nogueiras
Diabetes 2014
Design, Synthesis, Biological Screening, and Molecular Docking Studies of Piperazine-Derived Constrained Inhibitors of DPP-IV for the Treatment of Type 2 Diabetes
RN Kushwaha, R Srivastava, A Mishra, AK Rawat, AK Srivastava, W Haq, SB Katti
Chemical Biology & Drug Design 2014
Amelioration of Glycemic Control by Sleeve Gastrectomy and Gastric Bypass in a Lean Animal Model of Type 2 Diabetes: Restoration of Gut Hormone Profile
H Eickhoff, TM Louro, PN Matafome, F Vasconcelos, RM Seiça, FC Sousa
Obesity Surgery 2014
Insulin Secretion Induced by Glucose-dependent Insulinotropic Polypeptide Requires Phosphatidylinositol 3-Kinase   in Rodent and Human  -Cells
J Kolic, AF Spigelman, AM Smith, JE Fox, PE MacDonald
The Journal of biological chemistry 2014
Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors
X Ji, C Xia, J Wang, M Su, L Zhang, T Dong, Z Li, X Wan, J Li, J Li, L Zhao, Z Gao, H Jiang, H Liu
European Journal of Medicinal Chemistry 2014
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
Islets of Langerhans, 2. ed
MS Islam
Islets of Langerhans, 2. ed. 2014
Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor
K Tatarkiewicz, EJ Sablan, CJ Polizzi, C Villescaz, DG Parkes
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2014
Islets of Langerhans
S Islam
2014
Amelioration of Glycemic Control by Sleeve Gastrectomy and Gastric Bypass in a Lean Animal Model of Type 2 Diabetes: Restoration of Gut Hormone Profile
H Eickhoff, TM Louro, PN Matafome, F Vasconcelos, RM Seiça, FC e Sousa
Obesity Surgery 2014
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapies on bone metabolism
E Ceccarelli, EG Guarino, D Merlotti, A Patti, L Gennari, R Nuti, F Dotta
Frontiers in Endocrinology 2013
Pulmonary GLP-1 Receptor Increases at Birth and Exogenous GLP-1 Receptor Agonists Augmented Surfactant-Protein Levels in Litters From Normal and Nitrofen-Treated Pregnant Rats
M Romaní-Pérez, V Outeiriño-Iglesias, M Gil-Lozano, LC González-Matías, F Mallo, E Vigo
Endocrinology 2013
AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration
K Tajima, J Shirakawa, Y Togashi, H Inoue, K Sato, K Orime, Y Ito, M Kaji, E Sakamoto, A Nakamura, K Aoki, Y Goshima, T Atsumi, Y Terauchi, N Irwin
PloS one 2013
Impact of intestinal electrical stimulation on nutrient-induced GLP-1 secretion in vivo
D Sandoval, A Dunki-Jacobs, J Sorrell, RJ Seeley, DD D'Alessio
Neurogastroenterology & Motility 2013
Exendin (5-39), an antagonist of GLP-1 receptor, modulates synaptic transmission via glutamate uptake in the dentate gyrus
K Kobayashi, T Iwai, S Sasaki-Hamada, G Kamanaka, JI Oka
Brain Research 2013
Functional characterization of Cdkal1, a risk factor of type 2 diabetes, and the translational opportunities
S Watanabe, FY Wei, K Tomizawa
Drug Discovery Today: Disease Models 2013
Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication
G Gu, B Roland, K Tomaselli, CS Dolman, C Lowe, JS Heilig
The Journal of Comparative Neurology 2013
Design and Synthesis of 4-(2,4,5-Trifluorophenyl)butane-1,3-diamines as Dipeptidyl Peptidase IV Inhibitors
L Zhu, Y Li, L Qiu, M Su, X Wang, C Xia, Y Qu, J Li, J Li, B Xiong, J Shen
ChemMedChem 2013
Activin A, exendin-4, and glucose stimulate differentiation of human pancreatic ductal cells
HS Kim, SH Hong, SH Oh, JH Kim, MS Lee, MK Lee
Journal of Endocrinology 2013
The required beta cell research for improving treatment of type 2 diabetes
B Thorens
Journal of Internal Medicine 2013
A novel glucagon-like peptide 1 peptide identified from Ophisaurus harti: A NOVEL GLP1 PEPTIDE IDENTIFIED FROM O. HARTI
J Zhu, X Huang, H Gao, Q Bao, Y Zhao, JF Hu, G Xia
Journal of Peptide Science 2013
Glucagon-like peptide-1: modulator of β -cell dysfunction and death
D Rondas, W D'Hertog, L Overbergh, C Mathieu
Diabetes, Obesity and Metabolism 2013
The modulatory role of high fat feeding on gastrointestinal signals in obesity
FA Duca, Y Sakar, M Covasa
The Journal of Nutritional Biochemistry 2013
Resistin regulates pituitary lipid metabolism and inflammation in vivo and in vitro
F Rodriguez-Pacheco, MG Novelle, MJ Vazquez, E Garcia-Escobar, F Soriguer, G Rojo-Martinez, E García-Fuentes, MM Malagon, C Dieguez
Mediators of Inflammation 2013
Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER
V Gigoux, D Fourmy
Frontiers in Endocrinology 2013
Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes: Research Letter
Y Nagai, E Hashimoto, R Oikawa, S Asai, Y Terashima, Y Nakamura, Y Sasaki, H Tsukiyama, H Fukuda, T Ohshige, H Kato, A Ohta, Y Tanaka
Diabetes Obesity and Metabolism 2013
Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials (胰高血糖素样肽-1受体激动剂的使用与骨折的关系:一项对随机临床试验的meta分析): GLP-1Ra and bone fractures
G Mabilleau, A Mieczkowska, D Chappard
Journal of Diabetes 2013
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
L Bloemendaal, JS Kulve, SE la Fleur, RG Ijzerman, M Diamant
Journal of Endocrinology 2013
Cardiovascular Effects of Incretins in Diabetes
A Advani, A Bugyei-Twum, KA Connelly
Canadian Journal of Diabetes 2013
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering
AN Hegde
Reference Module in Chemistry, Molecular Sciences and Chemical Engineering 2013
An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
A Puddu, F Mach, A Nencioni, GL Viviani, F Montecucco
Mediators of Inflammation 2013
GLP-1-derived nonapeptide GLP-1(28–36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice
W Ip, W Shao, YA Chiang, T Jin
American journal of physiology. Endocrinology and metabolism 2013
Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
CM Edwards
BRIT J HOSP MED 2013
Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
JH Ellenbroek, HA Töns, MJ van Meeteren, N de Graaf, MA Hanegraaf, TJ Rabelink, F Carlotti, EJ de Koning
Diabetologia 2013
Glucagon-Like Peptide-1 and its Cardiovascular Effects
KS Heo, K Fujiwara, J Abe
Current Atherosclerosis Reports 2012
Cardiovascular Biology of the Incretin System
JR Ussher, DJ Drucker
Endocrine reviews 2012
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
FS Willard, KW Sloop
Experimental Diabetes Research 2012
Glucagon secretion and signaling in the development of diabetes
HY Gaisano, PE Macdonald, M Vranic
Frontiers in physiology 2012
Possible Role of GLP-1 and Its Agonists in the Treatment of Type 1 Diabetes Mellitus
CM Issa, ST Azar
Current Diabetes Reports 2012
Functional importance of GLP-1 receptor species and expression levels in cell lines
LB Knudsen, S Hastrup, CR Underwood, BS Wulff, J Fleckner
Regulatory Peptides 2012
Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity
FA Duca, M Covasa
British Journal of Nutrition 2012
Targeting the glucagon receptor family for diabetes and obesity therapy
YM Cho, CE Merchant, TJ Kieffer
Pharmacology & Therapeutics 2012
Biophysical and Pharmacological Properties of Glucagon-Like Peptide-1 in Rats Under Isoflurane Anesthesia:
T Kawano, K Tanaka, H Chi, S Eguchi, F Yamazaki, S Kitamura, N Kumagai, M Yokoyama
Anesthesia & Analgesia 2012
Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity
KS Panickar
Molecular Nutrition & Food Research 2012
The structure and function of the glucagon-like peptide-1 receptor and its ligands
D Donnelly
British Journal of Pharmacology 2012
A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer
WY Chiu, SR Shih, CH Tseng
Experimental Diabetes Research 2012
The Anorectic Effect of GLP-1 in Rats Is Nutrient Dependent
D Sandoval, JG Barrera, MA Stefater, S Sisley, SC Woods, DD DAlessio, RJ Seeley, A Siegel
PloS one 2012
Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms
J Zhang, RC Ritter
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2012
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro
S Baldassano, GD Wang, F Mulè, JD Wood
AJP Gastrointestinal and Liver Physiology 2012
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2011
Hypothalamic control of energy and glucose metabolism
S Sisley, D Sandoval
Reviews in Endocrine and Metabolic Disorders 2011
GLP-1, the gut-brain, and brain-periphery axes
C Cabou, R Burcelin
The review of diabetic studies : RDS 2011
Absence of the Glucagon-Like Peptide-1 Receptor Does Not Affect the Metabolic Phenotype of Mice with Liver-Specific Gsα Deficiency
M Chen, E Mema, J Kelleher, N Nemechek, A Berger, J Wang, T Xie, O Gavrilova, DJ Drucker, LS Weinstein
Endocrinology 2011
Liraglutide: A review of its therapeutic use as a once daily GLP-1 analog for the management of type 2 diabetes mellitus
M Dharmalingam, U Sriram, MP Baruah
Indian journal of endocrinology and metabolism 2011
The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
M Shimoda, Y Kanda, S Hamamoto, K Tawaramoto, M Hashiramoto, M Matsuki, K Kaku
Diabetologia 2011
Fish Physiology
NR Bury, D Boyle, CA Cooper
Homeostasis and Toxicology of Essential Metals 2011
The emerging role of the intestine in metabolic diseases
WD Bradley, C Zwingelstein, CM Rondinone
Archives Of Physiology And Biochemistry 2011
Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota
TD Swartz, FA Duca, T Wouters, Y Sakar, M Covasa
British Journal of Nutrition 2011
Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes
M Jean, M Alameh, MD Buschmann, A Merzouki
Gene Therapy 2011
Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125
Y Miyamoto, Y Banno, T Yamashita, T Fujimoto, S Oi, Y Moritoh, T Asakawa, O Kataoka, K Takeuchi, N Suzuki, K Ikedo, T Kosaka, S Tsubotani, A Tani, M Funami, M Amano, Y Yamamoto, K Aertgeerts, J Yano, H Maezaki
Bioorganic & Medicinal Chemistry 2011
Reprogramming gut and pancreas endocrine cells to treat diabetes
E Tudurí, TJ Kieffer
Diabetes, Obesity and Metabolism 2011
Processing of proglucagon to GLP-1 in pancreatic  -cells: is this a paracrine mechanism enabling GLP-1 to act on  -cells?
NM Whalley, LE Pritchard, DM Smith, A White
Journal of Endocrinology 2011
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus
M Hillman, L Eriksson, L Mared, K Helgesson, M Landin-Olsson
Journal of Cystic Fibrosis 2011
DPP-4 inhibitors in the treatment of type 2 diabetes
H Duez, B Cariou, B Staels
Biochemical Pharmacology 2011
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick
Williams Textbook of Endocrinology 2011
Update on incretin hormones : Update on incretin hormones
LK Phillips, JB Prins
Annals of the New York Academy of Sciences 2011
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro
S Baldassano, GD Wang, F Mulè, JD Wood
American journal of physiology. Gastrointestinal and liver physiology 2011
Dynamics of plasma active GLP-1 versus insulin and glucose concentrations during GLP-1 infusion in rat model of postprandial hyperglycemia
J Eiki, T Yada
Endocrine Journal 2011
A High-Fat, High-Fructose Diet Accelerates Nutrient Absorption and Impairs Net Hepatic Glucose Uptake in Response to a Mixed Meal in Partially Pancreatectomized Dogs
KC Coate, G Kraft, M Lautz, M Smith, DW Neal, AD Cherrington
The Journal of nutrition 2011
Handbook of Behavior, Food and Nutrition
VR Preedy, RR Watson, CR Martin
2011
Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell
AJ Mulherin, AH Oh, H Kim, A Grieco, LM Lauffer, PL Brubaker
Endocrinology 2011
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
Comprehensive Physiology
R Terjung
Comprehensive Physiology 2010
GIP: No Longer the Neglected Incretin Twin?
RN Kulkarni
Science Translational Medicine 2010
Type 2 Diabetes: An Expanded View of Pathophysiology and Therapy
J Unger, CG Parkin
Postgraduate Medicine 2010
Burger's Medicinal Chemistry and Drug Discovery
S Bruno, L Ronda, S Faggiano, S Bettati, A Mozzarelli
Burger's Medicinal Chemistry and Drug Discovery 2010
Textbook of Diabetes
PM Jones, SJ Persaud
Textbook of Diabetes 2010
Analogue-Based Drug Discovery II
J Fischer, CR Ganellin, A Ganesan, J Proudfoot
Analogue-Based Drug Discovery II 2010
Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals
T Nakamori
Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals 2010
Incretins: clinical perspectives, relevance, and applications for the primary care physician in the treatment of patients with type 2 diabetes mellitus
J Unger
Mayo Clinic proceedings. Mayo Clinic 2010
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
BL Furman
Toxicon 2010
Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
BP Cummings, KL Stanhope, JL Graham, DG Baskin, SC Griffen, C Nilsson, A Sams, LB Knudsen, K Raun, PJ Havel
Diabetes 2010
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets
KW Sloop, FS Willard, MB Brenner, J Ficorilli, K Valasek, AD Showalter, TB Farb, JX Cao, AL Cox, MD Michael, SM Sanfeliciano, MJ Tebbe, MJ Coghlan
Diabetes 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
The Physiology of Glucagon
GJ Taborsky
Journal of diabetes science and technology 2010
Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM
GG Kelley, OG Chepurny, F Schwede, HG Genieser, CA Leech, MW Roe, X Li, I Dzhura, E Dzhura, P Afshari, GG Holz
Islets 2010
Treatment of diabetes with glucagon-like peptide-1 gene therapy
MJ Riedel, TJ Kieffer
Expert Opinion on Biological Therapy 2010
Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal
L Yang, X Li, Y Ji, AB Kohan, DQ Wang, PN Howles, DY Hui, J Lai, P Tso
AJP Gastrointestinal and Liver Physiology 2010
Odyssey between Scylla and Charybdis through storms of carbohydrate metabolism and diabetes: a career retrospective
M Vranic
American journal of physiology. Endocrinology and metabolism 2010
Structure, Function, and Regulation of Insulin-Degrading Enzyme
RE Hulse, LA Ralat, WJ Tang
Vitamins and hormones 2009
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard
2009
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard
2009
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard
2009
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard
2009
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard
2009
Ca v 1.2 and Ca v 1.3 Are Differentially Coupled to Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion in the Pancreatic β-Cell Line INS-1
SM Jacobo, ML Guerra, GH Hockerman
The Journal of pharmacology and experimental therapeutics 2009
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
R Abu-Hamdah, A Rabiee, GS Meneilly, RP Shannon, DK Andersen, D Elahi
The Journal of clinical endocrinology and metabolism 2009
Cellular Peptide Hormone Synthesis and Secretory Pathways
JF Rehfeld, JR Bundgaard
2009
Pax6 Haploinsufficiency Causes Abnormal Metabolic Homeostasis by Down-Regulating Glucagon-Like Peptide 1 in Mice
J Ding, Y Gao, J Zhao, H Yan, S Guo, Q Zhang, L Li, X Gao
Endocrinology 2009
Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue
K Retterstøl
Expert Opinion on Investigational Drugs 2009
Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP
R Mentlein
Best Practice & Research Clinical Endocrinology & Metabolism 2009
Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity
H Ghanaat-Pour, Å Sjöholm
Diabetes/Metabolism Research and Reviews 2009
Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2'-O-Me-cAMP-AM
GG Kelley, OG Chepurny, F Schwede, HG Genieser, CA Leech, MW Roe, X Li, I Dzhura, E Dzhura, P Afshari, GG Holz
Islets 2009
The influences of juvenile diabetes on memory and hippocampal plasticity in rats: Improving effects of glucagon-like peptide-1
T Iwai, M Suzuki, K Kobayashi, K Mori, Y Mogi, JI Oka
Neuroscience Research 2009
Appropriate, timely, and rational treatment of type 2 diabetes mellitus: Meeting the challenges of primary care
J Unger, CG Parkin
Insulin 2009
Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity
C Mapelli, SI Natarajan, JP Meyer, MM Bastos, MS Bernatowicz, VG Lee, J Pluscec, DJ Riexinger, ES Sieber-McMaster, KL Constantine, CA Smith-Monroy, R Golla, Z Ma, DA Longhi, D Shi, L Xin, JR Taylor, B Koplowitz, CL Chi, A Khanna, GW Robinson, R Seethala, IA Antal-Zimanyi, RH Stoffel, S Han, JM Whaley, CS Huang, J Krupinski, WR Ewing
Journal of Medicinal Chemistry 2009
Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake
DA Sandoval, D Bagnol, SC Woods, DA D'Alessio, RJ Seeley
Diabetes 2008
CNS GLP-1 regulation of peripheral glucose homeostasis
D Sandoval
Physiology & Behavior 2008
Transplantation of PC1/3-Expressing α-cells Improves Glucose Handling and Cold Tolerance in Leptin-resistant Mice
RD Wideman, SL Gray, SD Covey, GC Webb, TJ Kieffer
Molecular Therapy 2008
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications
S Onoue, S Misaka, S Yamada
Naunyn-Schmiedeberg's Archives of Pharmacology 2008
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome
hellström, näslund, edholm, schmidt, kristensen, theodorsson, holst, efendic
Neurogastroenterology & Motility 2008
Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol
A Gangemi, P Salehi, B Hatipoglu, J Martellotto, B Barbaro, JB Kuechle, M Qi, Y Wang, P Pallan, C Owens, J Bui, D West, B Kaplan, E Benedetti, J Oberholzer
American Journal of Transplantation 2008
The Use of Exenatide in Islet Transplant Recipients with Chronic Allograft Dysfunction: Safety, Efficacy, and Metabolic Effects
T Froud, RN Faradji, A Pileggi, S Messinger, DA Baidal, GM Ponte, PE Cure, K Monroy, A Mendez, G Selvaggi, C Ricordi, R Alejandro
Transplantation 2008
Handbook of Prebiotics
F Guarner
Handbook of Prebiotics 2008
ROLE OF BRAIN PROSTANOIDS IN GLUCAGON-LIKE PEPTIDE-1-INDUCED CENTRAL ACTIVATION OF SYMPATHO-ADRENOMEDULLARY OUTFLOW IN RATS
J Arai, S Okada, N Yamaguchi-shima, T Shimizu, T Sasaki, M Yorimitsu, H Wakiguchi, K Yokotani
Clinical and Experimental Pharmacology and Physiology 2008
The physiology and pharmacology of incretins in type 2 diabetes mellitus
JJ Holst
Diabetes, Obesity and Metabolism 2008
Upregulation of the brainstem preproglucagon system in the obese Zucker rat
N Vrang, PJ Larsen, PB Jensen, K Lykkegaard, A Artmann, LK Larsen, M Tang-Christensen
Brain Research 2008
Low, but Physiological, Concentration of GLP-1 Stimulates Insulin Secretion Independent of the cAMP-Dependent Protein Kinase Pathway
M Shigeto, M Katsura, M Matsuda, S Ohkuma, K Kaku
Journal of Pharmacological Sciences 2008
Dietary Fiber in the Prevention and Treatment of Metabolic Syndrome: A Review
A Aleixandre, M Miguel
Critical Reviews in Food Science and Nutrition 2008
The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions
J Girard
Diabetes & Metabolism 2008
GLP-1 et système nerveux : un mécanisme de son action antidiabétique
R Burcelin, M Massebœuf, C Cabou
Médecine des Maladies Métaboliques 2008
Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice
H Su, M He, H Li, Q Liu, J Wang, Y Wang, W Gao, L Zhou, J Liao, AA Young, MW Wang, HH Schmidt
PloS one 2008
Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation
Z Liu, JF Habener
The Journal of biological chemistry 2008
Beyond Glycemic Control
CL Martin
The Diabetes Educator 2008
Insulin as a physiological modulator of glucagon secretion
P Bansal, Q Wang
American journal of physiology. Endocrinology and metabolism 2008
Managing the β-cell with GLP-1 in type 2 diabetes
B Gallwitz
The British Journal of Diabetes & Vascular Disease 2008
Pancreatic Beta Cell in Health and Disease
S Seino, GI Bell
2008
GPR119: “Double-Dipping” for Better Glycemic Control
L Lauffer, R Iakoubov, PL Brubaker
Endocrinology 2008
Identification of Glucose-Dependent Insulin Secretion Targets in Pancreatic β Cells by Combining Defined-Mechanism Compound Library Screening and siRNA Gene Silencing
W Wu, J Shang, Y Feng, CM Thompson, S Horwitz, JR Thompson, ED Macintyre, NA Thornberry, K Chapman, YP Zhou, AD Howard, J Li
Journal of biomolecular screening 2008
Intestinal Regulation of Glucose
Daniel J. Drucker
Journal of Clinical Investigation 2007
Mechanisms of action of glucagon-like peptide 1 in the pancreas
ME Doyle, JM Egan
Pharmacology & Therapeutics 2007
Dendritic cell–expanded, islet-specific CD4 + CD25 + CD62L + regulatory T cells restore normoglycemia in diabetic NOD mice
KV Tarbell, L Petit, X Zuo, P Toy, X Luo, A Mqadmi, H Yang, M Suthanthiran, S Mojsov, RM Steinman
Journal of Experimental Medicine 2007
Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug
I Idris, R Donnelly
Diabetes, Obesity and Metabolism 2007
Biology of Incretins: GLP-1 and GIP
LL Baggio, DJ Drucker
Gastroenterology 2007
Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes
RE Pratley, A Salsali
Current Medical Research and Opinion 2007
A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice
D Chen, J Liao, N Li, C Zhou, Q Liu, G Wang, R Zhang, S Zhang, L Lin, K Chen, X Xie, F Nan, AA Young, MW Wang
Proceedings of the National Academy of Sciences 2007
Effect of glucagon-like peptide-1 and -2 on regulation of food intake, body temperature and locomotor activity in the Japanese quail
S Shousha, K Nakahara, T Nasu, T Sakamoto, N Murakami
Neuroscience Letters 2007
Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats
Y Nakade, K Tsukamoto, M Iwa, TN Pappas, T Takahashi
Autonomic Neuroscience 2007
Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia: Possible Contribution to Impaired Incretin Effects in Diabetes
G Xu, H Kaneto, DR Laybutt, VF Duvivier-Kali, N Trivedi, K Suzuma, GL King, GC Weir, S Bonner-Weir
Diabetes 2007
Quantitative trait loci for carbohydrate and total energy intake on mouse chromosome 17: congenic strain confirmation and candidate gene analyses ( Glo1 , Glp1r )
KG Kumar, AC Poole, B York, J Volaufova, A Zuberi, BK Richards
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2007
The Physiology of Glucagon-like Peptide 1
JJ Holst
Physiological reviews 2007
Diabetes: Rationale for Dipeptidyl Peptidase 4 Inhibitors: A New Class of Oral Agents for the Treatment of Type 2 Diabetes Mellitus
RK Campbell
The Annals of pharmacotherapy 2007
Glucagon-like peptide-1 stimulates GABA formation by pancreatic β-cells at the level of glutamate decarboxylase
C Wang, R Mao, MV de Casteele, D Pipeleers, Z Ling
American journal of physiology. Endocrinology and metabolism 2007
Pharmacotherapy of Diabetes: New Developments
CE Mogensen
2007
Discovery and Structure−Activity Relationships of Piperidinone- and Piperidine-Constrained Phenethylamines as Novel, Potent, and Selective Dipeptidyl Peptidase IV Inhibitors
Z Pei, X Li, TW von Geldern, K Longenecker, D Pireh, KD Stewart, BJ Backes, C Lai, TH Lubben, SJ Ballaron, DW Beno, AJ Kempf-Grote, HL Sham, JM Trevillyan
Journal of Medicinal Chemistry 2007
Gastrointestinal hormones regulating appetite
O Chaudhri, C Small, S Bloom
Philosophical Transactions of the Royal Society B: Biological Sciences 2006
Major contributions of comparative endocrinology to the development and exploitation of the incretin concept
JM Conlon, S Patterson, PR Flatt
Journal of Experimental Zoology Part A: Comparative Experimental Biology 2006
Gut?Brain Axis: Regulation of Glucose Metabolism
AC Heijboer, H Pijl, AM van Hoek, LM Havekes, JA Romijn, EP Corssmit
Journal of Neuroendocrinology 2006
Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005
JJ Holst
Diabetologia 2006
Glucagon-Like Peptide-2: Update of the Recent Clinical Trials
PB Jeppesen
Gastroenterology 2006
Newer therapeutic options for children with diabetes mellitus: theoretical and practical considerations
GS Jeha, RA Heptulla
Pediatric Diabetes 2006
Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures
CM Mack, CX Moore, CM Jodka, S Bhavsar, JK Wilson, JA Hoyt, JL Roan, C Vu, KD Laugero, DG Parkes, AA Young
International Journal of Obesity 2006
“The next big thing” in diabetes: clinical progress on DPP-IV inhibitors
TW von Geldern, JM Trevillyan
Drug Development Research 2006
Increased insulin resistance and β cell activity in patients with Crohn's disease
N Bregenzer, A Hartmann, U Strauch, J Schölmerich, T Andus, LC Bollheimer
Inflammatory Bowel Diseases 2006
Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1)
RD Wideman, IL Yu, TD Webber, CB Verchere, JD Johnson, AT Cheung, TJ Kieffer
Proceedings of the National Academy of Sciences 2006
GLP-1 based therapy for type 2 diabetes
DK Arulmozhi, B Portha
European Journal of Pharmaceutical Sciences 2006
Using Evolutionary Information and Ancestral Sequences to Understand the Sequence–Function Relationship in GLP-1 Agonists
M Skovgaard, JT Kodra, DX Gram, SM Knudsen, D Madsen, DA Liberles
Journal of Molecular Biology 2006
Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin
T Adachi, T Tanaka, K Takemoto, T Koshimizu, A Hirasawa, G Tsujimoto
Biochemical and Biophysical Research Communications 2006
Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not
K Raun, P Voss, CF Gotfredsen, V Golozoubova, B Rolin, LB Knudsen
Diabetes 2006
Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide
Y Yamada, K Miyawaki, K Tsukiyama, N Harada, C Yamada, Y Seino
Diabetes 2006
Physiology of the Gastrointestinal Tract
DJ Drucker
Physiology of the Gastrointestinal Tract 2006
Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action
V Ionut, IF Liberty, K Hucking, M Lottati, D Stefanovski, D Zheng, RN Bergman
American journal of physiology. Endocrinology and metabolism 2006
Discovery, Structure−Activity Relationship, and Pharmacological Evaluation of (5-Substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as Potent Dipeptidyl Peptidase IV Inhibitors
Z Pei, X Li, K Longenecker, TW von Geldern, PE Wiedeman, TH Lubben, BA Zinker, K Stewart, SJ Ballaron, MA Stashko, AK Mika, DW Beno, M Long, H Wells, AJ Kempf-Grote, DJ Madar, TS McDermott, L Bhagavatula, MG Fickes, D Pireh, LR Solomon, MR Lake, R Edalji, EH Fry, HL Sham, JM Trevillyan
Journal of Medicinal Chemistry 2006
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
MJ Theodorakis, O Carlson, S Michopoulos, ME Doyle, M Juhaszova, K Petraki, JM Egan
American journal of physiology. Endocrinology and metabolism 2005
Prevalence, predisposition and prevention of type II diabetes
D Cheng
Nutrition & Metabolism 2005
A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome
H Yamamoto, T Mori, H Tsuchihashi, H Akabori, H Naito, T Tani
Digestive Diseases and Sciences 2005
Significance of Prohormone Convertase 2, PC2, Mediated Initial Cleavage at the Proglucagon Interdomain Site, Lys70-Arg71, to Generate Glucagon
A Dey, GM Lipkind, Y Rouillé, C Norrbom, J Stein, C Zhang, R Carroll, DF Steiner
Endocrinology 2005
Alpha cell function in health and disease: influence of glucagon-like peptide-1
BE Dunning, JE Foley, B Ahrén
Diabetologia 2005
The incretins: a link between nutrients and well-being
R Burcelin
British Journal of Nutrition 2005
The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management
OA Roges, M Baron, A Philis-Tsimikas
Expert Opinion on Investigational Drugs 2005
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier, MA Nauck
Diabetes/Metabolism Research and Reviews 2005
Exenatide: a novel treatment of Type 2 diabetes
B Ahren
Therapy 2005
Gastrointestinal Physiology
WC Orr
Principles and Practice of Sleep Medicine 2005
The [pre-] history of the incretin concept
W Creutzfeldt
Regulatory Peptides 2005
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
T Hansotia, DJ Drucker
Regulatory Peptides 2005
Glucagon-like peptide 1 and its derivatives in the treatment of diabetes
MA Nauck, JJ Meier
Regulatory Peptides 2005
Dipeptidyl peptidase IV inhibitors for type 2 diabetes and metabolic syndrome
PE Wiedeman, JM Trevillyan
Drug Discovery Today: Therapeutic Strategies 2005
Gluco-Incretins Control Insulin Secretion at Multiple levels As Revealed In Mice Lacking GLP-1 And GIP Receptors
Frédéric Preitner, Mark Ibberson, Isobel Franklin, Christophe Binnert, Mario Pende, Asllan Gjinovci, Tanya Hansotia, Daniel J. Drucker, Claes Wollheim, Rémy Burcelin, Bernard Thorens
Journal of Clinical Investigation 2004
Targeting β-cell cyclic 3′5′adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review
B Furman, N Pyne, P Flatt, F O'Harte
Journal of Pharmacy and Pharmacology 2004
Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects
E Näslund, N King, S Mansten, N Adner, JJ Holst, M Gutniak, PM Hellström
British Journal of Nutrition 2004
Gut peptides in the treatment of diabetes mellitus
TP Vahl, DA D’Alessio
Expert Opinion on Investigational Drugs 2004
Glucagon-like peptide-1 and glucagon-like peptide-2
LL Baggio, DJ Drucker
Best Practice & Research Clinical Endocrinology & Metabolism 2004
Islet replacement vs. regeneration: Hope or hype?
V Ramiya, D Schatz
Pediatric Diabetes 2004
New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells
GG Holz, G Holz
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004
Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?
CF Deacon, B Ahrén, JJ Holst
Expert Opinion on Investigational Drugs 2004
Aminomethylpyridines as DPP-IV inhibitors
JU Peters, S Weber, S Kritter, P Weiss, A Wallier, D Zimmerli, M Boehringer, M Steger, BM Loeffler
Bioorganic & Medicinal Chemistry Letters 2004
Gastro-intestinal hormones GIP and GLP-1
TJ Kieffer
Annales d'Endocrinologie 2004
Fish proglucagon genes have differing coding potential
L Zhou, DM Irwin
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2004
Mechanisms of glucose sensing and multiplicity of glucose sensors
B Thorens
Annales d'Endocrinologie 2004
Identification and Characterization of a Glucagon Receptor from the Goldfish Carassius auratus: Implications for the Evolution of the Ligand Specificity of Glucagon Receptors in Vertebrates
BK Chow, TW Moon, RL Hoo, CM Yeung, M Müller, PJ Christos, S Mojsov
Endocrinology 2004
Glucose-dependent insulinotropic polypeptide: its role in glucose and lipid homeostasis
CC Tseng
Current Opinion in Endocrinology & Diabetes 2003
Sounding board: diabetes mellitus in the elderly: a truly heterogeneous entity?
S Ratnakant, ME Ochs, SS Solomon
Diabetes, Obesity and Metabolism 2003
Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
DJ Drucker
Expert Opinion on Investigational Drugs 2003
Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2
PL Brubaker, Y Anini
Canadian Journal of Physiology and Pharmacology 2003
Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells
A Suzuki, H Nakauchi, H Taniguchi
Proceedings of the National Academy of Sciences 2003
Different role of intracellular loops of glucagon-like peptide-1 receptor in G-protein coupling
A Bavec, M Hällbrink, Ü Langel, M Zorko
Regulatory Peptides 2003
Glucose-dependent insulinotropic polypeptide: its role in glucose and lipid homeostasis:
CC Tseng
Current Opinion in Endocrinology & Diabetes 2003
[2-Sulfo-9-fluorenylmethoxycarbonyl]3–exendin-4—a long-acting glucose-lowering prodrug
Y Shechter, H Tsubery, M Fridkin
Biochemical and Biophysical Research Communications 2003
Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons
N Vrang, CB Phifer, MM Corkern, HR Berthoud
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2003
Clinical Significance of GLP-2 in Short-Bowel Syndrome
PB Jeppesen
The Journal of nutrition 2003
Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide: Potential Applications in Type 2 Diabetes Mellitus
JJ Meier, B Gallwitz, MA Nauck
BioDrugs 2003
Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1
D Delmeire, D Flamez, SA Hinke, JJ Cali, D Pipeleers, F Schuit
Diabetologia 2003
Enhancing bowel adaptation in short bowel syndrome
PB Jeppesen, PB Mortensen
Current Gastroenterology Reports 2002
Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1
LL Baggio, DJ Drucker
Treatments in Endocrinology 2002
Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis
Z Gao, RA Young, MM Trucco, SR Greene, EL Hewlett, FM Matschinsky, BA Wolf
Biochemical Journal 2002
Insulin Resistance and Insulin Resistance Syndrome
A Cincotta
Insulin Resistance and Insulin Resistance Syndrome 2002
Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis
DJ Drucker
Molecular Endocrinology 2002
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective
CF Deacon, JJ Holst
Biochemical and Biophysical Research Communications 2002
Biological actions and therapeutic potential of the glucagon-like peptides
DJ Drucker
Gastroenterology 2002
Structure-Function of the Glucagon Receptor Family of G Protein-Coupled Receptors: The Glucagon, GIP, GLP-1, and GLP-2 Receptors
PL Brubaker, DJ Drucker
Receptors and Channels 2002
Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats
Y Anini, T Hansotia, PL Brubaker
Endocrinology 2002
cDNA Cloning of Proglucagon from the Stomach and Pancreas of the Dog
DM Irwin
Mitochondrial DNA 2001
Amphibian glucagon family peptides: potent metabolic regulators in fish hepatocytes
TP Mommsen, JM Conlon, DM Irwin
Regulatory Peptides 2001
The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the l-arginine/nitric oxide pathway
T Tolessa, E Näslund, PM Hellström
Regulatory Peptides 2001
Identification of a Proglucagon cDNA from Rana tigrina rugulosa That Encodes Two GLP-1s and That Is Alternatively Spliced in a Tissue-Specific Manner
CM Yeung, BK Chow
General and Comparative Endocrinology 2001
Evolution of receptors for proglucagon-derived peptides: isolation of frog glucagon receptors
P Sivarajah, MB Wheeler, DM Irwin
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2001
New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2
D J Drucker, J Lovshin, L Baggio, M Nian, F Adatia, R P Boushey, Y Liu, J Saleh, B Yusta, L Scrocchi
Annals of the New York Academy of Sciences 2001
GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve
A Brandt, M Katschinski, R Arnold, KS Polonsky, B Göke, MM Byrne
American journal of physiology. Endocrinology and metabolism 2001
A Glucagon-Like Peptide-1 Receptor Agonist and an Antagonist Modify Macronutrient Selection by Rats
CT Peters, YH Choi, PL Brubaker, GH Anderson
The Journal of nutrition 2001
An Interaction between Hypothalamic Glucagon-Like Peptide-1 and Macronutrient Composition Determines Food Intake in Rats
YH Choi, GH Anderson
The Journal of nutrition 2001
Monounsaturated Fatty Acid Diets Improve Glycemic Tolerance through Increased Secretion of Glucagon-Like Peptide-1*
AS Rocca, J LaGreca, J Kalitsky, PL Brubaker
Endocrinology 2001
Molecular Basis of Pancreas Development and Function
JF Habener, MA Hussain
2001
Ontogeny of intestinal nutrient transport
A Thiesen, G Wild, M Keelan, MT Clandinin, M McBurney, JV Aerde, AB Thomson
Canadian Journal of Physiology and Pharmacology 2000
Fructo-Oligosaccharide Supplementation: Effects on Metabolic, Endocrine and Hematological Traits in Veal Calves
J Kaufhold, HM Hammon, JW Blum
Journal of Veterinary Medicine Series A 2000
Proglucagon cDNAs from the Leopard Frog, Rana pipiens, encode two GLP-1-like peptides
DM Irwin, P Sivarajah
Molecular and Cellular Endocrinology 2000
Effect of Glucagon-Like Peptide 1(7-36)Amide in Insulin-Treated Patients with Diabetes Mellitus Secondary to Chronic Pancreatitis
C Hedetoft, SP Sheikh, S Larsen, JJ Holst
Pancreas 2000
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon
PB Jeppesen, B Hartmann, J Thulesen, BS Hansen, JJ Holst, SS Poulsen, PB Mortensen
Gut 2000
Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research
JM Conlon
Regulatory Peptides 2000
Augmentation of Alimentary Insulin Secretion despite Similar Gastric Inhibitory Peptide (GIP) Responses in Juvenile Obesity
RA Heptulla, WV Tamborlane, M Cavaghan, M Bronson, C Limb, MA Yong-Zhan, RS Sherwin, S Caprio
Pediatric Research 2000
The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor
M Nishizawa, H Nakabayashi, K Kawai, T Ito, S Kawakami, A Nakagawa, A Niijima, K Uchida
Journal of the Autonomic Nervous System 2000
Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum
C Herrmann–Rinke, GP McGregor, B Göke
Peptides 2000
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish
S Mojsov
American Zoologist 2000
Glucagon-like Peptide-1 in Fishes: The Liver and Beyond
TP Mommsen
American Zoologist 2000
Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish1
S Mojsov
American Zoologist 2000
Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum
L Hansen, B Hartmann, T Bisgaard, H Mineo, PN Jørgensen, JJ Holst
American journal of physiology. Endocrinology and metabolism 2000
Adaptive changes in insulin secretion by islets from neonatal rats raised on a high-carbohydrate formula
M Srinivasan, R Aalinkeel, F Song, B Lee, SG Laychock, MS Patel
American journal of physiology. Endocrinology and metabolism 2000
Neuroendocrine Function and Response to Stress in Mice with Complete Disruption of Glucagon-Like Peptide-1 Receptor Signaling1
NJ MacLusky, S Cook, L Scrocchi, J Shin, J Kim, F Vaccarino, SL Asa, DJ Drucker
Endocrinology 2000
The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon Superfamily*
NM Sherwood, SL Krueckl, JE McRory
Endocrine reviews 2000
Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
M Hiroyoshi, K Tateishi, Y Yasunami, K Maeshiro, J Ono, Y Matsuoka, S Ikeda
The American Journal of Gastroenterology 1999
Encapsulated, Genetically Engineered Cells, Secreting Glucagon-like Peptide-1 for the Treatment of Non-insulin-dependent Diabetes Mellitus
R Burcelin, E Rolland, W Dolci, S Germain, V Carrel, B Thorens
Annals of the New York Academy of Sciences 1999
Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice
DQ Shih, MA Navas, S Kuwajima, SA Duncan, M Stoffel
Proceedings of the National Academy of Sciences 1999
Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1
R Burcelin, W Dolci, B Thorens
Metabolism 1999
Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha -deficient mice
DQ Shih, MA Navas, S Kuwajima, SA Duncan, M Stoffel
Proceedings of the National Academy of Sciences 1999
Insulin and Proglucagon-Derived Peptides from the Horned Frog, Ceratophrys ornata (Anura:Leptodactylidae)
AM White, SM Secor, JM Conlon
General and Comparative Endocrinology 1999
Immunoblockade of endogenous glucagon-like peptide-1 by monoclonal antibodies in conscious rats: Effect on the insulin response to intragastric glucose
J Delft, O Uttenthal, C Koch, M Ghiglione
Metabolism 1999
Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain
JA Chowen, FR Fonseca, E Alvarez, M Navarro, LM Garcı́a-Segura, E Blázquez
Neuropeptides 1999
Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice
B Ahrén, G Pacini
American journal of physiology. Endocrinology and metabolism 1999
Effect of GIP and GLP-1 antagonists on insulin release in the rat
CC Tseng, XY Zhang, MM Wolfe
American journal of physiology. Endocrinology and metabolism 1999
Role of the Vagus Nerve in Mediating Proximal Nutrient-Induced Glucagon-Like Peptide-1 Secretion*
AS Rocca, PL Brubaker
Endocrinology 1999
Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin
T Tolessa, M Gutniak, JJ Holst, S Efendic, PM Hellström
Journal of Clinical Investigation 1998
Glucagon-like peptide-1 (7–36) amide as a novel neuropeptide
E Blázquez, E Alvarez, M Navarro, I Roncero, F Rodríguez-Fonseca, JA Chowen, JA Zueco
Molecular Neurobiology 1998
Structure-function analysis of a series of glucagon-like peptide-1 analogs
JC Parker, KM Andrews, DM Rescek, W Massefski, GC Andrews, LG Contillo, RW Stevenson, DH Singleton, RT Suleske
The Journal of Peptide Research 1998
Stimulatory Transducing Systems in Pancreatic Islet Cellsa
S Emami, K Regnauld, N Ferrand, A Astesano, M Pessah, H Phan, C Boissard, JM Garel, G Rosselin
Annals of the New York Academy of Sciences 1998
Central infusion of glucagon-like peptide-1-(7–36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem
TE Thiele, RJ Seeley, D D'Alessio, J Eng, IL Bernstein, SC Woods, G Dijk
Brain Research 1998
Proglucagon and Glucose Transporter mRNA Is Altered by Diet and Disease Susceptibility in 30-Day-Old Biobreeding (BB) Diabetes-Prone and Normal Rats
RA Reimer, S Glen, CJ Field, MI McBurney
Pediatric Research 1998
Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms
T Tolessa, M Gutniak, J J Holst, S Efendic, P M Hellström
Digestive Diseases and Sciences 1998
Fermentable Dietary Fiber Increases GLP-1 Secretion and Improves Glucose Homeostasis Despite Increased Intestinal Glucose Transport Capacity in Healthy Dogs
SP Massimino, MI McBurney, CJ Field, AB Thomson, M Keelan, MG Hayek, GD Sunvold
The Journal of nutrition 1998
Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects
E Ferrannini
Endocrine reviews 1998
Effects of Aging and a High Fat Diet on Body Weight and Glucose Tolerance in Glucagon-Like Peptide-1 Receptor−/− Mice*
LA Scrocchi, DJ Drucker
Endocrinology 1998
Glucagon-Like Peptide-1-(7–36)Amide Increases Pulmonary Surfactant Secretion through a Cyclic Adenosine 3′,5′-Monophosphate-Dependent Protein Kinase Mechanism in Rat Type II Pneumocytes*
E Benito, E Blazquez, MA Bosch
Endocrinology 1998
GLP-1 Receptors in Golden Syrian Hamster Islets: Identification and Functional Characterization
G Rosselin, V Leclercq-Meyer, C Boissart, M Pessah, WJ Malaisse
Endocrine 1998
Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid
M Anvari, C A Paterson, E E Daniel, T J McDonald
Digestive Diseases and Sciences 1998
Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release
PL Brubaker, S Efendic, GR Greenberg
Endocrine 1997
ENTEROGLUCAGON
JJ Holst
Annual Review of Physiology 1997
The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties
DM Irwin, M Satkunarajah, Y Wen, PL Brubaker, RA Pederson, MB Wheeler
Proceedings of the National Academy of Sciences 1997
Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon
Y Rouillé, M Bianchi, JC Irminger, PA Halban
FEBS Letters 1997
Acute Incretin Response to Oral Glucose Is Associated with Stimulation of Gastric Inhibitory Polypeptide, Not Glucagon-Like Peptide in Young Subjects
C Limb, WV Tamborlane, RS Sherwin, R Pederson, S Caprio
Pediatric Research 1997
Endoproteolysis of Glucagon-like Peptide (GLP)-1(7–36) amide by Ectopeptidases in RINm5F Cells
K Hupe-Sodmann, R Göke, B Göke, HH Thole, B Zimmermann, K Voigt, GP McGregor
Peptides 1997
Activation of the hepatic glycine cleavage enzyme system by glucagon and glucagon-related peptides
GM Mabrouk, JT Brosnan
Canadian Journal of Physiology and Pharmacology 1997
Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2
PL Brubaker, A Izzo, M Hill, DJ Drucker
American journal of physiology. Endocrinology and metabolism 1997
Physiology and Pathophysiology of the Islets of Langerhans
B Soria
1997
Circulating and Tissue Forms of the Intestinal Growth Factor, Glucagon-Like Peptide-2*
PL Brubaker, A Crivici, A Izzo, P Ehrlich, CH Tsai, DJ Drucker
Endocrinology 1997
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons
DA D'Alessio, R Vogel, R Prigeon, E Laschansky, D Koerker, J Eng, JW Ensinck
Journal of Clinical Investigation 1996
Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37)
YA Hosokawa, H Hosokawa, C Chen, JL Leahy
Journal of Clinical Investigation 1996
Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat
CC Tseng, TJ Kieffer, LA Jarboe, TB Usdin, MM Wolfe
Journal of Clinical Investigation 1996
Regulation of glucagon-like peptide-I receptor expression and transcription by the protein kinase C pathway
HC Fehmann, J Schweinfurth, J Jiang, B Göke
Research in Experimental Medicine 1996
Wege der Nachrichtenübermittlung bei der Stimulation der Sekretion von Insulin
HP Ammon
Pharmazie in unserer Zeit 1996
Time-dependent effects of cholinergic stimulation on beta cell responsiveness
WS Zawalich, KC Zawalich, GG Kelley
Pflügers Archiv - European Journal of Physiology 1996
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene
LA Scrocchi, TJ Brown, N Maclusky, PL Brubaker, AB Auerbach, AL Joyner, DJ Drucker
Nature Medicine 1996
Pancreatic β-Cell Receptors and G Proteins Coupled to Adenylyl Cyclase
JC Marie, G Rosselin, G Skoglund
Annals of the New York Academy of Sciences 1996
On the Effects of Glucagon-Like Peptide-1 on Blood Glucose Regulation in Normal and Diabetic Subjects
JJ Holst, MB Toft-Nielsen, C Ørskov, M Nauck, B Willms
Annals of the New York Academy of Sciences 1996
Synthesis and Biochemical Characterization of Proglucagon- Related Peptides
N Yanaihara, T Mochizuki, T Satoh, S Imai, K Sasaki, H Kakuyama, H Hosoe, N Takatsuka, K Iguchi, WQ Luo, N Kurokawa, C Yanaihara
Annals of the New York Academy of Sciences 1996
Endoprotease Regulation of Miniglucagon Production
D Bataille, P Blache, F Bergeron
Annals of the New York Academy of Sciences 1996
Induction of intestinal epithelial proliferation by glucagon-like peptide 2
DJ Drucker, P Erlich, SL Asa, PL Brubaker
Proceedings of the National Academy of Sciences 1996
Proglucagon processing in islet and intestinal cell lines
JD Tucker, S Dhanvantari, PL Brubaker
Regulatory Peptides 1996
Expression of glucagon-like peptide 1 receptor in a murine C cell line Regulation of calcitonin gene by glucagon-like peptide 1
Y Lamari, C Boissard, MS Moukhtar, A Jullienne, G Rosselin, JM Garel
FEBS Letters 1996
Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol
WS Zawalich, KC Zawalich
Metabolism 1996
Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1
H Nakabayashi, M Nishizawa, A Nakagawa, R Takeda, A Niijima
American journal of physiology. Endocrinology and metabolism 1996
Mechanisms of inhibition of insulin release
GW Sharp
American journal of physiology. Cell physiology 1996
Glucagon III
PJ Lefèbvre
1996
Glucagon-like peptide-1 is a physiological incretin in rat
Z Wang, RM Wang, AA Owji, DM Smith, MA Ghatei, SR Bloom
Journal of Clinical Investigation 1995
Drugs on the Horizon for Treatment of Type 2 Diabetes
J Rachman, RC Turner
Diabetic Medicine 1995
Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis
YT Kruszynska, MA Ghatei, SR Bloom, N McIntyre
Hepatology 1995
Mechanism of action of glucagon-like peptide-17–36NH2 in isolated rat pancreatic islets and abrogation of its effects in long-term incubations
KA Gronau, PL Brubaker
Endocrine 1995
Synthesis and secretion of glucagon-like peptide-1 by fetal rat intestinal cells in culture
TH Huang, PL Brubaker
Endocrine 1995
Glucagon-like peptide-1(7–36)amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat
JC Calvo, CV Gisolfi, E Blazquez, F Mora
Brain Research Bulletin 1995
Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7–36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides
K Hupe-Sodmann, GP McGregor, R Bridenbaugh, R Göke, B Göke, H Thole, B Zimmermann, K Voigt
Regulatory Peptides 1995
Advances in Drug Research
CL Crespi
Advances in Drug Research 1995
Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic beta-cells by the insulinotropic hormone glucagon-like peptide-1
GG 4th, CA Leech, JF Habener
The Journal of biological chemistry 1995
Activation of a cAMP-regulated Ca2+-Signaling Pathway in Pancreatic β-Cells by the Insulinotropic Hormone Glucagon-like Peptide-1*
GG Holz, CA Leech, JF Habener
The Journal of biological chemistry 1995
Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion
X Jia, JC Brown, P Ma, RA Pederson, CH McIntosh
American journal of physiology. Endocrinology and metabolism 1995
Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1
GG Holz, CA Leech, JF Habener
The Journal of biological chemistry 1995
Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like Peptide
Y Rouillé, S Martin, DF Steiner
The Journal of biological chemistry 1995
Evidence that glucagon stimulates insulin secretion through its own receptor in rats
K Kawai, C Yokota, S Ohashi, Y Watanabe, K Yamashita
Diabetologia 1995
Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (?TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells
, M Janen, B Gke
Acta Diabetologica 1995
Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus: Effect of sulfonylurea therapy
N Fukase, H Manaka, K Sugiyama, H Takahashi, M Igarashi, M Daimon, K Yamatani, M Tominaga, H Sasaki
Acta Diabetologica 1995
The pathogenesis of NIDDM: the role of the pancreatic beta cell.
Zawalich WS, Kelley GG
Diabetologia 1995
Structure/Activity Characterization of Glucagon-Like Peptide-1
B Gallwitz, M Witt, G Paetzold, C Morys-Wortmann, B Zimmermann, K Eckart, UR Folsch, WE Schmidt
European Journal of Biochemistry 1994
Interaction of glucagon-like peptide-I (7–37) and somatostatin-14 on signal transduction and proinsulin gene expression in βTC-1 cells
HC Fehmann, M Strowski, B Göke
Metabolism 1994
Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas
K Tateishi, K Shima, A Funakoshi, Y Yasunami, N Iwamoto, Y Matsuoka
Diabetes Research and Clinical Practice 1994
The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects
D Elahi, M McAloon-Dyke, NK Fukagawa, GS Meneilly, AL Sclater, KL Minaker, JF Habener, DK Andersen
Regulatory Peptides 1994
A novel procedure for the preparation of biologically active recombinant peptides using a cyanylation reaction
N Koyama, M Kuriyama, N Amano, O Nishimura
Journal of Biotechnology 1994
Primary structures of peptides derived from proglucagon isolated from the pancreas of the elasmobranch fish, Scyliorhinus canicula
JM Conlon, N Hazon, L Thim
Peptides 1994
Glucagonlike peptide 1: A newly discovered gastrointestinal hormone
JJ Holst
Gastroenterology 1994
Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice
DJ Drucker
American journal of physiology. Endocrinology and metabolism 1994
Molecular Biology of Diabetes
B Draznin, D LeRoith
1994
Physiologic relevance of heterogeneity in the pancreatic beta-cell population
D Pipeleers, R Kiekens, Z Ling, A Wilikens, F Schuit
Diabetologia 1994
Structure-activity studies of glucagon-like peptide-1
K Adelhorst, BB Hedegaard, LB Knudsen, O Kirk
The Journal of biological chemistry 1994
Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells
T Yada, M Sakurada, K Ihida, M Nakata, F Murata, A Arimura, M Kikuchi
The Journal of biological chemistry 1994
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
MA Nauck, MM Heimesaat, C Orskov, JJ Holst, R Ebert, W Creutzfeldt
Journal of Clinical Investigation 1993
Metabolic and endocrine functions of glucagon-like peptides — evolutionary and biochemical perspectives
TP Mommsen, EM Plisetskaya
Fish Physiology and Biochemistry 1993
Hypersecretion of Truncated Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide in Obese Patients
N Fukase, M Igarashi, H Takahashi, H Manaka, K Yamatani, M Daimon, M Tominaga, H Sasaki
Diabetic Medicine 1993
Structure and biological activity of glucagon and glucagon-like peptide from a primitive bony fish, the bowfin (Amia calva)
JM Conlon, JH Youson, TP Mommsen
Biochemical Journal 1993
Influence of glucagon-like peptide-1 on β cell responsiveness
WS Zawalich, KC Zawalich, H Rasmussen
Regulatory Peptides 1993
Glucagon-like peptide-I-(7–37) suppresses hyperglycemia in rats
GK Hendrick, A Gjinovci, LA Baxter, S Mojsov, CB Wollheim, JF Habener, GC Weir
Metabolism 1993
Effects of glucagon-like peptide-1(7-36)amide on the concentrations of insulin and glucose in sheep
PA Martin, A Faulkner
Comparative Biochemistry and Physiology Part A: Physiology 1993
Neurotrophic Factors
DN Ishii
Neurotrophic Factors 1993
Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)
GG Holz, WM Kiihtreiber, JF Habener
Nature 1993
The Incretin Notion and its Relevance to Diabetes
JF Habener
Endocrinology and metabolism clinics of North America 1993
Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation
MA Nauck, M Bsing, C rskov, EG Siegel, J Talartschik, A Baartz, T Baartz, UT Hopt, , W Creutzfeldt
Acta Diabetologica 1993
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
A Wettergren, B Schjoldager, PE Mortensen, J Myhre, J Christiansen, JJ Holst
Digestive Diseases and Sciences 1993
Peptides 1992
CH Schneider, AN Eberle
1993
Gut hormones and diabetes mellitus
W Creutzfeldt, M Nauck
Diabetes / Metabolism Reviews 1992
Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin
HC Fehmann, R Göke, B Göke
Molecular and Cellular Endocrinology 1992
Decrease in plasma GLP-1 immunoreactivity in starved rats
J Takahashi, Y Noma, S Yoshimoto, C Fujita, K Shima
Diabetes Research and Clinical Practice 1992
Coexistence of glucagon and pancreatic polypeptide in human and rat pancreatic endocrine cells
IS Park, M Bendayan
Endocrine Pathology 1992
Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man
R Eissele, R Göke, S Willemer, HP Harthus, H Vermeer, R Arnold, B Göke
European Journal of Clinical Investigation 1992
Comparison of the effect of GIP and GLP-1 (7–36amide) on insulin release from rat pancreatic islets
EG Siegel, A Schulze, WE Schmidt, W Creutzfeldt
European Journal of Clinical Investigation 1992
Signal transduction crosstalk in the endocrine system: pancreatic β-cells and the glucose competence concept
GG Holz, JF Habener
Trends in Biochemical Sciences 1992
Structural requirements for biological activity of glucagon-like peptide-I
S Mojsov
International Journal of Peptide and Protein Research 1992
Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone
HC Fehmann, JF Habener
Trends in Endocrinology & Metabolism 1992
Solubilization of active GLP-1 (7–36)amide receptors from RINm5F plasma membranes
R Göke, B Oltmer, SP Sheikh, B Göke
FEBS Letters 1992
Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept
GG Holz, JF Habener
Trends in Biochemical Sciences 1992
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1
B Thorens
Proceedings of the National Academy of Sciences 1992
Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain
LO Uttenthal, A Toledano, E Blázquez
Neuropeptides 1992
Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas
S Suzuki, K Kawai, S Ohashi, Y Watanabe, K Yamashita
Metabolism 1992
Diabetes and Atherosclerosis
RW Stout
1992
Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4
JP Raufman, L Singh, G Singh, J Eng
The Journal of biological chemistry 1992
Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene
PL Brubaker, YC Lee, DJ Drucker
The Journal of biological chemistry 1992
Glucagon-like peptide-1, a new hormone of the entero-insular axis
C Orskov
Diabetologia 1992
Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine
C Orskov, J Jeppesen, S Madsbad, JJ Holst
Journal of Clinical Investigation 1991
Priming effect of glucagon-like peptide-1 (7–36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas
HC Fehmann, R Göke, B Göke, R Bächle, B Wagner, R Arnold
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1991
Hormonal regulation of metabolism in hepatocytes of the ureogenic teleostopsanus beta
TP Mommsen, E Danulat, PJ Walsh
Fish Physiology and Biochemistry 1991
Glucagon-like peptide-1(7–36) amide is a new incretin/enterogastrone candidate
R Göke, HC Fehmann, B Göke
European Journal of Clinical Investigation 1991
Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7–37) on a somatostatin secreting cell line
HC Fehmann, JF Habener
FEBS Letters 1991
Hyperglycaemia but not hyperinsulinaemia prevents the secretion of glucagon-like peptide-1 (7-36 amide) stimulated by fat ingestion
H Takahashi, H Manaka, K Suda, N Fukase, A Sekikawa, H Eguchi, M Tominaga, H Sasaki
Scandinavian Journal of Clinical & Laboratory Investigation 1991
Absence of insulinotropic glucagon-like peptide-I(7–37) receptors on isolated rat liver hepatocytes
PF Blackmore, S Mojsov, JH Exton, JF Habener
FEBS Letters 1991
Characterization of glucagon-like peptide-I(7–36)amide receptors of rat lung membranes by covalent cross-linking
G Richter, R Göke, B Göke, H Schmidt, R Arnold
FEBS Letters 1991
International Review of Cytology
RA Miller
International Review of Cytology 1991
The primary structure of Glucagon-like peptide but not insulin has been conserved between the American eel, Anguilla rostrata and the European eel, Anguilla anguilla
JM Conlon, PC Andrews, L Thim, TW Moon
General and Comparative Endocrinology 1991
Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy
J Miholic, C rskov, JJ Holst, J Kotzerke, HJ Meyer
Digestive Diseases and Sciences 1991
Endocrine pancreas of teleost fish: A model for interaction of islet hormones?
EM Plisetskaya
Journal of Experimental Zoology 1990
Gut signals for islet hormone release
R Ebert
European Journal of Clinical Investigation 1990
Alterations of plasma immunoreactive glucagon-like peptide-1 behavior in non-insulin-dependent diabetics
M Hirota, M Hashimoto, M Hiratsuka, C Ohboshi, S Yoshimoto, M Yano, A Mizuno, K Shima
Diabetes Research and Clinical Practice 1990
Characterization of receptors for glucagon-like peptide-1(7–36) amide on rat lung membranes
G Richter, R Göke, B Göke, R Arnold
FEBS Letters 1990
Gastrointestinal Endocrinology
CC Wang, YH Tu, WY Zhu
Gastrointestinal Endocrinology 1990
Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7–36 amide) without affect on mRNA level in isolated rat islets
E Yamato, Y Noma, Y Tahara, H Ikegami, Y Yamamoto, T Cha, H Yoneda, T Ogihara, C Ohboshi, M Hirota, K Shima
Biochemical and Biophysical Research Communications 1990
Action of glucagon and glucagon-like peptide on glycogen metabolism of trout isolated hepatocytes
AC Puviani, C Otiolenghi, ME Gavioli, E Fabbri, L Brighenti
Comparative Biochemistry and Physiology Part B: Comparative Biochemistry 1990
Effect of Glucagon-Like Peptide-1 on Gastric Somatostatin and Gastrin Secretion in the Rat
R Eissele, H Koop, R Arnold
Scandinavian Journal of Gastroenterology 1990
The epidermal growth factor precursor isolated from murine kidney membranes. Chemical characterization and biological properties
JA Breyer, S Cohen
The Journal of biological chemistry 1990
Functional characterization of a cAMP-responsive element of the rat insulin I gene
J Philippe, M Missotten
The Journal of biological chemistry 1990
Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom
J Eng, PC Andrews, WA Kleinman, L Singh, JP Raufman
The Journal of biological chemistry 1990
Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas
S Mojsov, MG Kopczynski, JF Habener
The Journal of biological chemistry 1990
A physiologic role for somatostatin 28 as a regulator of insulin secretion
DA D'Alessio, C Sieber, C Beglinger, JW Ensinck
Journal of Clinical Investigation 1989
Effects of four orally administered analogues of prostaglandin E1and E2on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man
M Nauck, S Härter, R Ebert, W Creutzfeldt
European Journal of Clinical Investigation 1989
Glycogenolytic action of glucagon-family peptides and epinephrine on catfish hepatocytes
C Ottolenghi, AC Puviani, ME Gavioli, E Fabbri, L Brighenti, EM Plisetskaya
Fish Physiology and Biochemistry 1989
Internalization of glucagon-like peptide-1(7–36)amide in rat insulinoma cells
R Göke, G Richter, B Göke, M Trautmann, R Arnold
Research in Experimental Medicine 1989
Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine
DJ Drucker, PL Brubaker
Proceedings of the National Academy of Sciences 1989
Synergistic stimulatory effect of glucagon-like peptide-1 (7–36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas
HC Fehmann, B Göke, R Göke, ME Trautmann, R Arnold
FEBS Letters 1989
Metabolic effects of salmon glucagon and glucagon-like peptide in coho and chinook salmon
EM Plisetskaya, C Ottolenghi, MA Sheridan, TP Mommsen, A Gorbman
General and Comparative Endocrinology 1989
Distribution and molecular forms of glucagon-like peptide in the dog
K Suda, H Takahashi, N Fukase, H Manaka, M Tominaga, H Sasaki
Life Sciences 1989
The Comparative Physiology of Regulatory Peptides
S Holmgren
1989
GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans
BT Schjoldager, PE Mortensen, J Christiansen, C rskov, JJ Holst
Digestive Diseases and Sciences 1989
Complete Sequences of Glucagon-like Peptide-1 from Human and Pig Small Intestine
C Orskov, M Bersani, AH Johnsen, P Højrup, JJ Holst
The Journal of biological chemistry 1989
Proglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles
JM Conlon
Diabetologia 1988
Glucagon-like peptide-1 (7–36 amide): a potent glucagonostatic and insulinotropic hormone
T Matsuyama, R Komatsu, M Namba, N Watanabe, H Itoh, S Tarui
Diabetes Research and Clinical Practice 1988
Comparison of half-disappearance times, distribution volumes and metabolic clearance rates of exogenous glucagon-like peptide 1 and glucagon in rats
I Oshima, M Hirota, C Ohboshi, K Shima
Regulatory Peptides 1988
Effect of glucagon-like peptide-1 on insulin secretion
K Shima, M Hirota, C Ohboshi
Regulatory Peptides 1988
Effect of truncated glucagon-like peptide 1 on cAMP in rat gastric glands and HGT-1 human gastric cancer cells
AB Hansen, CP Gespach, GE Rosselin, JJ Holst
FEBS Letters 1988
Truncated glucagon-like peptide-1 (proglucagon 78–107 amide), an intestinal insulin-releasing peptide, has specific receptors on rat insulinoma cells (RIN 5AH)
C Ørskov, JH Nielsen
FEBS Letters 1988
Identification and characterization of glucagon-like peptide-1 7–36 amide-binding sites in the rat brain and lung
SM Kanse, B Kreymann, MA Ghatei, SR Bloom
FEBS Letters 1988
Isolation of alligator gar (Lepisosteus spatula) glucagon, oxyntomodulin, and glucagon-like peptide: Amino acid sequences of oxyntomodulin and glucagon-like peptide
HG Pollock, JR Kimmel, KE Ebner, JW Hamilton, JB Rouse, V Lance, AB Rawitch
General and Comparative Endocrinology 1988
Peptides
GR Marshall
Peptides 1988
Colocalization of glucagon-like peptide and glucagon immunoreactivities in pancreatic islets and intestine of salmonids
M Nozaki, K Miyata, Y Oota, A Gorbman, EM Plisetskaya
Cell and Tissue Research 1988
GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN
B Kreymann, MA Ghatei, G Williams, SR Bloom
The Lancet 1987
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
DJ Drucker, J Philippe, S Mojsov, WL Chick, JF Habener
Proceedings of the National Academy of Sciences 1987
Glucagon-like peptides activate hepatic gluconeogenesis
TP Mommsen, PC Andrews, EM Plisetskaya
FEBS Letters 1987
Effect of the enteroinsular axis on both the A- and B-cell response to arginine after oral glucose in man
I Shimizu, M Hirota, C Ohboshi, A Mizuno, K Shima
Diabetologia 1987
Pancreatic and intestinal processing of proglucagon in man
C Orskov, J J Holst, S S Poulsen, P Kirkegaard
Diabetologia 1987
Progress in Medicinal Chemistry
JR Brown, SH Imam
Progress in Medicinal Chemistry 1985
Advances in Metabolic Disorders
G Aurbach, JT Potts
Advances in Metabolic Disorders 1964

← Previous 1 2 3 4 … 30 31 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 4 news outlets
Blogged by 2
Posted by 1 X users
Referenced in 6 patents
Referenced in 10 Wikipedia pages
206 readers on Mendeley
1 readers on CiteULike
See more details